<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <atom:link rel="self" type="application/rss+xml" href="https://escholarship.org/uc/ucb_sph/rss"/>
    <ttl>720</ttl>
    <title>Recent ucb_sph items</title>
    <link>https://escholarship.org/uc/ucb_sph/rss</link>
    <description>Recent eScholarship items from School of Public Health</description>
    <pubDate>Sat, 5 Sep 2026 08:56:03 +0000</pubDate>
    <item>
      <title>Repeated sampling of different individuals within the same clusters to improve precision of longitudinal estimators: the DISC design</title>
      <link>https://escholarship.org/uc/item/8j63p4vf</link>
      <description>BACKGROUND: Longitudinal studies often involve repeated cluster sampling of a population at multiple time points, such as in difference-in-differences (DID) studies. Although cohort designs typically lead to more efficient estimators relative to repeated cross-sectional (RCS) designs, they are often impractical.
METHODS: We describe the DISC (Different Individuals, Same Clusters) design, a sampling scheme that improves the precision of estimators in these settings. The DISC design represents a hybrid between a cohort and an RCS design, in which the researcher takes a single sample of clusters at baseline, but takes different cross-sectional samples of individuals within clusters at each time point.
RESULTS: We show analytically that the DISC design yields DID estimators with much higher precision relative to an RCS design, particularly if cluster effects are present. For example, for a design with two surveys, 40 clusters, and 25 individuals per cluster, the variance of a commonly...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8j63p4vf</guid>
      <pubDate>Mon, 31 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Downey, Jordan</name>
      </author>
      <author>
        <name>Kenny, Avi</name>
      </author>
    </item>
    <item>
      <title>Impacts of land use and fallowing on coccidioidomycosis incidence in California: A population-based longitudinal study</title>
      <link>https://escholarship.org/uc/item/5mw5f0dd</link>
      <description>Coccidioidomycosis (Valley fever) is a growing public health concern in the western U.S., with California reporting more than an eightfold rise in cases over the past two decades. As climate change, groundwater regulation, and prolonged drought drive major agricultural land-use shifts in the state, including widespread retirement of cultivated lands (i.e., fallowing), understanding their effects on this soil-borne fungal infection is critical. We linked 65,657 confirmed, geolocated cases (2008-2021) to high-resolution maps distinguishing natural vegetation, crop types, and fallowed fields to quantify how land use and land cover were associated with disease rates. Flexible statistical models showed that natural land covers, shrubland, barren ground, and grassland, were associated with higher incidence. Some agricultural uses (grain/hay, field crops, corn, and cotton) were associated with higher incidence, whereas others (orchards, rice, and truck crops/berries) were associated...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5mw5f0dd</guid>
      <pubDate>Fri, 28 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Heaney, Alexandra K</name>
      </author>
      <author>
        <name>Jones, Isabel J</name>
      </author>
      <author>
        <name>Camponuri, Simon K</name>
      </author>
      <author>
        <name>Head, Jennifer R</name>
      </author>
      <author>
        <name>Weaver, Amanda K</name>
      </author>
      <author>
        <name>Collender, Philip A</name>
      </author>
      <author>
        <name>Cooksey, Gail Sondermeyer</name>
      </author>
      <author>
        <name>Jain, Seema</name>
      </author>
      <author>
        <name>Vugia, Duc</name>
      </author>
      <author>
        <name>Balmes, John</name>
        <uri>https://orcid.org/0000-0002-2246-7002</uri>
      </author>
      <author>
        <name>Eisen, Ellen A</name>
        <uri>https://orcid.org/0000-0002-5114-5264</uri>
      </author>
      <author>
        <name>Adebiyi, Adeyemi</name>
        <uri>https://orcid.org/0000-0001-7091-6872</uri>
      </author>
      <author>
        <name>Taylor, John</name>
      </author>
      <author>
        <name>Bhattachan, Abinash</name>
      </author>
      <author>
        <name>Remais, Justin V</name>
        <uri>https://orcid.org/0000-0002-0223-4615</uri>
      </author>
    </item>
    <item>
      <title>Reconstructing pathogen-specific antibody binding epitopes and age-dependent immune signatures from proteomic-scale peptide libraries.</title>
      <link>https://escholarship.org/uc/item/4tr012gj</link>
      <description>High-density peptide arrays are useful for mapping linear antibody epitopes and resolution of antibody specificity in a single-assay platform. Here, we used peptide library screening to evaluate magnitude and breadth of humoral responses to enteric pathogens in the context of public health interventions. We characterized the epitope landscape to known immunogenic proteins to several viruses, bacteria, and parasites and used that to infer immunological profiles at age 3, 14, and 28 months. The peptide libraries detected immune signatures better for viruses compared with bacteria and parasites and captured distinct dynamics of protein-level variation in immune signatures over time. We found limited sensitivity for bacterial and protozoan pathogens whose humoral responses may depend more on conformational or natively modified epitopes than linear-peptide binding. Unbiased peptide libraries have potential utility for broad analysis of antibody responses in integrated serosurveillance,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4tr012gj</guid>
      <pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Kamau, Everlyn</name>
        <uri>https://orcid.org/0000-0003-4285-2255</uri>
      </author>
      <author>
        <name>Walas, Nikolina</name>
      </author>
      <author>
        <name>Zhang, Minlu</name>
        <uri>https://orcid.org/0000-0003-2347-0569</uri>
      </author>
      <author>
        <name>Kamath, Kathy</name>
        <uri>https://orcid.org/0000-0001-6143-3414</uri>
      </author>
      <author>
        <name>Reifert, Jack</name>
      </author>
      <author>
        <name>Shon, John</name>
        <uri>https://orcid.org/0000-0001-9465-6286</uri>
      </author>
      <author>
        <name>Ali, Shahjahan</name>
        <uri>https://orcid.org/0000-0003-3883-1208</uri>
      </author>
      <author>
        <name>Rahman, Md Ziaur</name>
      </author>
      <author>
        <name>Shoab, Abul K</name>
      </author>
      <author>
        <name>Famida, Syeda L</name>
      </author>
      <author>
        <name>Akther, Salma</name>
      </author>
      <author>
        <name>Hossen, Md Saheen</name>
      </author>
      <author>
        <name>Mutsuddi, Palash</name>
      </author>
      <author>
        <name>Rahman, Mahbubur</name>
        <uri>https://orcid.org/0000-0003-0520-2683</uri>
      </author>
      <author>
        <name>Grembi, Jessica A</name>
        <uri>https://orcid.org/0000-0001-6142-4913</uri>
      </author>
      <author>
        <name>Mertens, Andrew N</name>
        <uri>https://orcid.org/0000-0002-1050-6721</uri>
      </author>
      <author>
        <name>Charles, Richelle C</name>
        <uri>https://orcid.org/0000-0002-8881-1849</uri>
      </author>
      <author>
        <name>Leung, Daniel T</name>
        <uri>https://orcid.org/0000-0001-8401-0801</uri>
      </author>
      <author>
        <name>Luby, Stephen</name>
        <uri>https://orcid.org/0000-0001-5385-899X</uri>
      </author>
      <author>
        <name>Lin, Audrie</name>
        <uri>https://orcid.org/0000-0002-3877-3469</uri>
      </author>
      <author>
        <name>Arnold, Benjamin F</name>
        <uri>https://orcid.org/0000-0001-6105-7295</uri>
      </author>
    </item>
    <item>
      <title>Challenges and opportunities for scaling up infection prevention and control programmes in rural district hospitals of Tamil Nadu, India</title>
      <link>https://escholarship.org/uc/item/9f3418kj</link>
      <description>Introduction:&amp;nbsp;The aim of this study was to explore the barriers to implementing an infection prevention and control (IPC) programme in three public district hospitals in Tamil Nadu by interviewing key stakeholders involved in the roll-out of the programme.
 Materials and methods:&amp;nbsp;Investigators conducted interviews (n&amp;nbsp;= 17) with chief medical officers (CMOs), physicians, and IPC nurses at three secondary public district hospitals and their affiliated primary health centres (PHCs).
 Results:&amp;nbsp;Six major themes emerged from the interviews: (1) prevalent IPC practices before the programme began; (2) barriers to implementation; (3) perceptions of the effectiveness of the IPC programme; (4) suggestions for future expansion of the programme; (5) the role of healthcare sanitation workers, and (6) water, sanitation and hygiene (WaSH) infrastructure. Stakeholders noted improvements in IPC knowledge, infection control related behaviour, and overall healthcare quality in...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9f3418kj</guid>
      <pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guhan, Maya</name>
      </author>
      <author>
        <name>Kumar, Mohan</name>
      </author>
      <author>
        <name>Butzin-Dozier, Zachary</name>
        <uri>https://orcid.org/0000-0001-6419-0008</uri>
      </author>
      <author>
        <name>Graham, Jay</name>
      </author>
    </item>
    <item>
      <title>Dismantling the United States Agency for International Development Costs Lives and Threatens Global Stability.</title>
      <link>https://escholarship.org/uc/item/7hj2h76m</link>
      <description>Dismantling the United States Agency for International Development Costs Lives and Threatens Global Stability.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7hj2h76m</guid>
      <pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Kayser, Georgia L</name>
      </author>
      <author>
        <name>Barrett, Christopher B</name>
      </author>
      <author>
        <name>Smith, Woutrina</name>
      </author>
      <author>
        <name>Lantagne, Daniele</name>
      </author>
      <author>
        <name>Brown, Joe</name>
      </author>
      <author>
        <name>Graham, Jay</name>
        <uri>https://orcid.org/0000-0001-7062-6293</uri>
      </author>
      <author>
        <name>Rogers, Beatrice Lorge</name>
      </author>
      <author>
        <name>Nyarko, Kwabena B</name>
      </author>
      <author>
        <name>Meeyam, Tongkorn</name>
      </author>
      <author>
        <name>Rees, Helen</name>
      </author>
    </item>
    <item>
      <title>Antimicrobial Resistance Gene Profiles in Integron-Positive and Integron-Negative Third-Generation Cephalosporin-Resistant E. coli from Human and Animal Sources</title>
      <link>https://escholarship.org/uc/item/7bm6p179</link>
      <description>&lt;b&gt;Background/Objectives&lt;/b&gt;: Integrons are genetic platforms that allow bacteria to acquire antimicrobial resistance (AMR) genes, making them a focal point for many AMR studies and surveillance programs. This study investigated how the prevalence of integrons (&lt;i&gt;intI&lt;/i&gt; and &lt;i&gt;attI&lt;/i&gt; genes) in third-generation cephalosporin-resistant &lt;i&gt;E. coli&lt;/i&gt; (3GCR-Ec) varied across three different sources (i.e., healthy children, domestic animals and urinary tract infections). The study aimed to determine how different classes of AMR genes vary among 3GCR-Ec with integrons present versus those where integrons are absent. &lt;b&gt;Methods&lt;/b&gt;: We analyzed 3GCR-Ec isolates collected from semirural parishes of Eastern Quito, Ecuador, that included: (1) 3GCR-Ec from healthy children (&lt;i&gt;n&lt;/i&gt; = 946), (2) 3GCR-Ec from domestic animal species (&lt;i&gt;n&lt;/i&gt; = 673), and 3GCR-Ec from patients with urinary tract infections (UTIs) (&lt;i&gt;n&lt;/i&gt; = 138). Genomic analyses were performed for all 1757 sequences...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7bm6p179</guid>
      <pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Ho, Tin</name>
      </author>
      <author>
        <name>Salinas, Liseth</name>
      </author>
      <author>
        <name>Trueba, Gabriel</name>
      </author>
      <author>
        <name>Amato, Heather K</name>
      </author>
      <author>
        <name>Walas, Nikolina</name>
      </author>
      <author>
        <name>Pandya, Mihir</name>
      </author>
      <author>
        <name>Johnson, Timothy</name>
      </author>
      <author>
        <name>Graham, Jay</name>
        <uri>https://orcid.org/0000-0001-7062-6293</uri>
      </author>
    </item>
    <item>
      <title>Cancer Screening and Citizenship Status in the US.</title>
      <link>https://escholarship.org/uc/item/77g6k7w6</link>
      <description>Importance: Immigrants without US citizenship, or noncitizens, disproportionately endure poverty, labor exclusions, and inadequate health care access-structural drivers of adverse cancer outcomes. While screening is critical for preventing cancer deaths, and cancer is the leading cause of death among noncitizens, little is known about citizenship status and its potential influence on cancer screening.
Objectives: To examine cancer screening inequities associated with citizenship status, evaluate whether these inequities vary across states, and determine whether structural factors mediate these inequities.
Design, Setting, and Participants: This cross-sectional study used nationally representative data from the National Health Interview Survey (2010-2023). Eligibility for cancer screening and the timing and types of tests considered appropriate were determined using US Preventive Services Task Force guidelines. Data were analyzed from May to August 2025.
Exposure: Citizenship status:...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/77g6k7w6</guid>
      <pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
      <author>
        <name>Chen, Stacy</name>
        <uri>https://orcid.org/0009-0004-9120-0995</uri>
      </author>
      <author>
        <name>Calip, Gregory S</name>
      </author>
      <author>
        <name>Bustamante, Arturo Vargas</name>
        <uri>https://orcid.org/0000-0003-0414-5015</uri>
      </author>
    </item>
    <item>
      <title>Oral and parenteral treatment with a third-generation cephalosporin promotes the proliferation of diverse ESBL-producing Escherichia coli in the chicken intestinal tract</title>
      <link>https://escholarship.org/uc/item/5pm463j2</link>
      <description>The global rise of antimicrobial resistance is a major public health threat, with &lt;i&gt;Escherichia coli&lt;/i&gt; facilitating the spread of extended-spectrum beta-lactamase (ESBL) genes like &lt;i&gt;bla&lt;/i&gt;&lt;sub&gt;CTX-M&lt;/sub&gt;, which confer resistance to third-generation cephalosporins (3GCs). This study examines the impact of 3GC treatment on resistant &lt;i&gt;E. coli&lt;/i&gt; clones and horizontal gene transfer (HGT) of ESBL genes in broiler chickens in Quito, Ecuador. Fifteen-day-old Ross broilers were divided into three groups: oral ceftriaxone (100 mg/kg), parenteral ceftriaxone (100 mg/kg intramuscular), and control (no treatment). The study included three phases: baseline, antimicrobial administration (5 days), and recovery (15 days). Fecal cultures on McConkey agar, with and without ceftriaxone (2 µg/mL), measured the ratio of 3GC-resistant lactose fermenters. Regardless of the administration route, ceftriaxone significantly increased resistant coliforms (&amp;gt;80%). Five &lt;i&gt;E. coli&lt;/i&gt; colonies...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5pm463j2</guid>
      <pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>López, Lázaro</name>
      </author>
      <author>
        <name>Jumbo, Melany</name>
      </author>
      <author>
        <name>Mosquera, Pamela</name>
      </author>
      <author>
        <name>Donoso, Gustavo</name>
      </author>
      <author>
        <name>Graham, Jay</name>
        <uri>https://orcid.org/0000-0001-7062-6293</uri>
      </author>
      <author>
        <name>Trueba, Gabriel</name>
      </author>
    </item>
    <item>
      <title>Extensive Overlap in Avian and Extraintestinal Pathogenic Escherichia coli Strains Between Backyard Poultry, Humans, and Dogs in Ecuador</title>
      <link>https://escholarship.org/uc/item/5gd3q1n1</link>
      <description>&lt;i&gt;Escherichia coli&lt;/i&gt; is a ubiquitous organism that colonizes a variety of animal hosts and has the ability to persist within the environment. As such, it is not surprising that animals frequently share &lt;i&gt;E. coli&lt;/i&gt; strains and contribute to environmental &lt;i&gt;E. coli&lt;/i&gt; ecology. It has been well documented that poultry meat can serve as a reservoir of avian pathogenic &lt;i&gt;E. coli&lt;/i&gt; (APEC) with the potential to cause human disease. However, the impact of backyard poultry rearing on household and community APEC sharing is less clear. In this study, we examined 1348 &lt;i&gt;E. coli&lt;/i&gt; isolates from children, dogs, and chickens in 222 households in peri-urban communities of Quito, Ecuador, sampled across five timepoints. Extensive overlap between isolates from all three host sources were identified using Clermont phylotyping and multilocus sequence typing. Human and dog isolates also had a high rate of carriage (37% and 49%, respectively) of genes indicative of APEC. Phylogenetic...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5gd3q1n1</guid>
      <pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Johnson, Timothy J</name>
      </author>
      <author>
        <name>Miller, Elizabeth A</name>
      </author>
      <author>
        <name>Flores-Figueroa, Cristian</name>
      </author>
      <author>
        <name>Munoz-Aguayo, Jeannette</name>
      </author>
      <author>
        <name>Amato, Heather</name>
      </author>
      <author>
        <name>Salinas, Liseth</name>
      </author>
      <author>
        <name>Trueba, Gabriel</name>
      </author>
      <author>
        <name>Graham, Jay P</name>
        <uri>https://orcid.org/0000-0001-7062-6293</uri>
      </author>
    </item>
    <item>
      <title>Tracking blaCTX-M transmission through transposable elements in uropathogenic and commensal E. coli</title>
      <link>https://escholarship.org/uc/item/4qv64837</link>
      <description>AIM: To investigate the nucleotide sequences associated with transposable elements carrying bla&lt;sub&gt;CTX-M&lt;/sub&gt; allelic variants as potential markers for the transmission of antimicrobial resistance genes between domestic animals, humans and the environment.
MATERIALS &amp;amp; METHODS: We conducted whole-genome sequencing and analyzed the nucleotide sequences of most abundant bla&lt;sub&gt;CTX-M&lt;/sub&gt; allelic variants (bla&lt;sub&gt;CTX-M-27&lt;/sub&gt;, bla&lt;sub&gt;CTX-M-55&lt;/sub&gt;, and bla&lt;sub&gt;CTX-M-65&lt;/sub&gt;) in commensal Escherichia coli (&lt;i&gt;n&lt;/i&gt; = 20) from household members in Quito and uropathogenic E. coli (UPEC) (&lt;i&gt;n&lt;/i&gt; = 149) isolated from nine clinics in Quito, Ecuador.
RESULTS: The Ecuadorian commensal &lt;i&gt;E. coli&lt;/i&gt; and UPEC displayed identical nucleotide sequences surrounding the &lt;i&gt;bla&lt;/i&gt;&lt;sub&gt;CTX-M&lt;/sub&gt; gene and the synteny was similar to those found in other parts of the world; however phylogenetic analysis indicated that the genetic environments in Ecuadorian isolates were unique.
CONCLUSION:...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4qv64837</guid>
      <pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guilcazo, Denyss</name>
      </author>
      <author>
        <name>Salinas, Liseth</name>
      </author>
      <author>
        <name>Chavez, Cristina</name>
      </author>
      <author>
        <name>Vasquez, Katherine</name>
      </author>
      <author>
        <name>Mendez, Gabriela I</name>
      </author>
      <author>
        <name>Price, Lance B</name>
      </author>
      <author>
        <name>Graham, Jay P</name>
        <uri>https://orcid.org/0000-0001-7062-6293</uri>
      </author>
      <author>
        <name>Eisenberg, Joseph NS</name>
      </author>
      <author>
        <name>Trueba, Gabriel</name>
      </author>
    </item>
    <item>
      <title>Field Evaluation of Do-It-Yourself Air Filtration Solutions for Evaporative Coolers to Reduce Ambient Particle Infiltration in Homes in Wildfire-Affected Communities</title>
      <link>https://escholarship.org/uc/item/9r6061xc</link>
      <description>Evaporative coolers (ECs) introduce outdoor air pollutants indoors when operating. This study evaluates the potential of do-it-yourself (DIY) air filtration solutions for ECs to cost-effectively reduce the infiltration of ambient fine particulate matter (PM&lt;sub&gt;2.5&lt;/sub&gt;) in homes with ECs using measurements in 48 homes in wildfire-affected agricultural communities in California. All homes received one portable air cleaner (PAC); 25 homes also received DIY filters (mostly MERV 13) attached to their ECs. PurpleAir monitors measured indoor and outdoor PM&lt;sub&gt;2.5&lt;/sub&gt; concentrations. PAC operation was monitored in all of the homes. EC usage was monitored in some homes and predicted using relative humidity dynamics in all homes. Conditional analyses between EC likely on and off conditions were used to evaluate the impacts of DIY EC filters on ambient PM&lt;sub&gt;2.5&lt;/sub&gt; infiltration, including during several wildfire-affected days. Median levels of ambient PM&lt;sub&gt;2.5&lt;/sub&gt; infiltration...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9r6061xc</guid>
      <pubDate>Wed, 19 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Wang, Mingyu</name>
      </author>
      <author>
        <name>Singh, Aditya</name>
      </author>
      <author>
        <name>Chang, David</name>
      </author>
      <author>
        <name>Kaser, Isabella</name>
      </author>
      <author>
        <name>Wagner, Jeff</name>
      </author>
      <author>
        <name>Wang, Zhong-Min</name>
      </author>
      <author>
        <name>Singer, Brett C</name>
        <uri>https://orcid.org/0000-0001-5665-4343</uri>
      </author>
      <author>
        <name>Miller, Shelly L</name>
      </author>
      <author>
        <name>Martinez, Nayamin</name>
      </author>
      <author>
        <name>Rodriguez, Ruben</name>
      </author>
      <author>
        <name>Jarmul, Stephanie</name>
      </author>
      <author>
        <name>Thompson, McKenna</name>
      </author>
      <author>
        <name>Reynolds, Peggy</name>
      </author>
      <author>
        <name>Von Behren, Julie</name>
      </author>
      <author>
        <name>Balmes, John R</name>
        <uri>https://orcid.org/0000-0002-2246-7002</uri>
      </author>
      <author>
        <name>Heidarinejad, Mohammad</name>
      </author>
      <author>
        <name>Stephens, Brent</name>
      </author>
      <author>
        <name>Solomon, Gina</name>
        <uri>https://orcid.org/0000-0001-6004-0387</uri>
      </author>
    </item>
    <item>
      <title>Field Testing of an Affordable Zero-Liquid-Discharge Arsenic-Removal Technology for a Small-Community Drinking Water System in Rural California</title>
      <link>https://escholarship.org/uc/item/7cn1247v</link>
      <description>Arsenic contamination in groundwater threatens public health, particularly in small, low-income communities lacking affordable treatment solutions. This study investigated the field implementation of novel air cathode assisted iron electrocoagulation (ACAIE) technology for arsenic removal in Allensworth, California, where groundwater arsenic concentrations exceeded 250 µg/L. Over four months, a pilot-scale ACAIE system, operating at 600 L/h, consistently reduced arsenic levels to below the EPA’s maximum contaminant level of 10 µg/L. Laboratory experiments informed the optimization of charge dosage and flow rates, which were validated during field testing of the ACAIE 600 L/h system. The in-situ generation of hydrogen peroxide at the cathode speeded up the reaction kinetics, ensuring high arsenic removal efficiency while allowing high throughput, even with a compact reactor size. An economic analysis demonstrated a treatment cost of USD 0.02/L excluding labor, highlighting the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7cn1247v</guid>
      <pubDate>Wed, 19 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Bandaru, Siva RS</name>
      </author>
      <author>
        <name>Smesrud, Logan</name>
      </author>
      <author>
        <name>Majmudar, Jay</name>
      </author>
      <author>
        <name>Hernandez, Dana</name>
        <uri>https://orcid.org/0000-0003-1030-0579</uri>
      </author>
      <author>
        <name>Wickliff, Paris</name>
      </author>
      <author>
        <name>Tseng, Winston</name>
      </author>
      <author>
        <name>Gadgil, Ashok</name>
        <uri>https://orcid.org/0000-0002-0357-9455</uri>
      </author>
    </item>
    <item>
      <title>Fathers’ Presence Makes a Difference During Children’s Evening Meals</title>
      <link>https://escholarship.org/uc/item/4rs047wt</link>
      <description>This observational study used descriptive analysis to improve understanding of the relationship between fathers’ presence or absence, the occurrence of mothers’ feeding practices, and child eating behaviors at evening meals. Participants were 141 Mexican-origin families with children aged 8 to 10 years. We coded behavioral observations of video-recorded meals. Three parental feeding practices were established a priori : (1) pressure to eat, (2) restriction of amount of food, and (3) positive involvement in child’s meals. Additionally, we identified child eating behaviors and food eaten. Fewer mothers engaged in certain types of positive involvement in child’s meals when fathers were present at the meals, compared to when fathers were absent. Regarding child eating behaviors, when fathers were present, more children engaged in positive talk about food, compared to when fathers were absent. Additionally, when fathers were present, more children ate grains and fewer ate fruit, compared...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4rs047wt</guid>
      <pubDate>Tue, 4 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Penilla, Carlos</name>
        <uri>https://orcid.org/0000-0002-2212-5432</uri>
      </author>
      <author>
        <name>Martinez, Suzanna M</name>
      </author>
      <author>
        <name>Deardorff, Julianna</name>
      </author>
      <author>
        <name>Tschann, Jeanne M</name>
      </author>
      <author>
        <name>Greenspan, Louise C</name>
      </author>
      <author>
        <name>Flores, Elena</name>
      </author>
      <author>
        <name>Pasch, Lauri A</name>
      </author>
    </item>
    <item>
      <title>A Randomized, Controlled Study of a Rural Sanitation Behavior Change Program in Madhya Pradesh, India</title>
      <link>https://escholarship.org/uc/item/8cc9s4zn</link>
      <description>Poor sanitation and open defecation are thought to be a major cause of diarrhea and intestinal parasite infections among young children. In 1999, India launched the Total Sanitation Campaign with the goal of achieving universal toilet coverage in rural India by 2012. This paper reports on a cluster-randomized, controlled trial that was conducted in 80 rural villages in Madhya Pradesh to measure the effect of the program on toilet access, sanitation behavior, and child health outcomes. The study analyzed a random sample of 3,039 households and 5,206 children under five years of age. Field staff collected baseline measures of sanitation conditions, behavior, and child health, and re-visited households 21 months later. The analysis finds that implementation of the program activities was slower than the original timeline (only 35 percent of villages were triggered more than six months before the follow-up survey). Nevertheless, the Total Sanitation Campaign successfully increased...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8cc9s4zn</guid>
      <pubDate>Mon, 3 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Patil, Sumeet R</name>
      </author>
      <author>
        <name>Arnold, Benjamin F</name>
        <uri>https://orcid.org/0000-0001-6105-7295</uri>
      </author>
      <author>
        <name>Salvatore, Alicia</name>
      </author>
      <author>
        <name>Briceno, Bertha</name>
      </author>
      <author>
        <name>Colford, Jr John M</name>
        <uri>https://orcid.org/0000-0002-3288-6956</uri>
      </author>
      <author>
        <name>Gertler, Paul J</name>
      </author>
    </item>
    <item>
      <title>Wealthy, healthy and wise: does money compensate for being born into difficult conditions?</title>
      <link>https://escholarship.org/uc/item/1k07550b</link>
      <description>Recent studies have linked transfers from Mexican conditional cash transfer programme Oportunidades (formerly PROGRESA) to improvements in child development (Fernald et al., 2008, 2009), but this work has been criticized as failing to account for endogeneity of the transfers. We create an exogenous instrument for the amount of transfers and use it to test programme and transfer effects. Applying the new instrument confirms that improvements in child development are more linked to the transfers themselves than to other portions of the programme, which involve medical check-ups as well as educational sessions for mothers.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1k07550b</guid>
      <pubDate>Mon, 3 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Manley, James</name>
      </author>
      <author>
        <name>Fernald, Lia</name>
        <uri>https://orcid.org/0000-0003-1555-4607</uri>
      </author>
      <author>
        <name>Gertler, Paul</name>
      </author>
    </item>
    <item>
      <title>Economic costs of TB and HIV in high-TB-burden countries</title>
      <link>https://escholarship.org/uc/item/7s33v6x9</link>
      <description>INTRODUCTION: Tuberculosis (TB) remains a significant health burden in 25 low- and middle-income countries. Despite TB being more cost-effective to prevent and treat its funding is disproportionately lower than that of HIV. This study aims to assess the economic costs of TB versus HIV and evaluate the returns on investment in TB prevention compared to HIV.
METHODS: The study uses a microfoundations behavioural model to estimate the economic costs of TB and HIV on households and the economy. We combine data from the WHO Global Tuberculosis Report, the Institute for Health Metrics and Evaluation's Global Burden of Disease dataset and Demographic Household Surveys among others. The analysis accounts for lost earnings and healthcare expenses in the short and long term.
RESULTS: The findings indicate that active TB cases result in significant economic losses, with US$13.7 billion in current annual losses, US$17.2 billion in future losses and US$5.7 billion in medical expenses, for...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7s33v6x9</guid>
      <pubDate>Thu, 30 Jul 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Barron, Manuel</name>
      </author>
      <author>
        <name>Bertozzi, Stefano</name>
        <uri>https://orcid.org/0000-0002-1723-7085</uri>
      </author>
      <author>
        <name>Gertler, Paul</name>
      </author>
    </item>
    <item>
      <title>A systematic review and meta-analysis of studies testing effects of cash transfers on child cognitive, language, and socio-emotional development in low- or middle income countries</title>
      <link>https://escholarship.org/uc/item/7pf6q86t</link>
      <description>Cash transfers alleviate financial hardship as either conditional programs, requiring behavioral compliance, or unconditional programs. We undertook a systematic review, quality appraisal, and meta-analysis of 16 RCTs following PRISMA guidelines, examining effects of cash transfers on child development among children&amp;nbsp;(n = 29,887, &amp;lt;8 years old) in low- or middle-income countries; papers were excluded if they used quasi-experimental or simulation methods, or did not have a control group without cash. To examine risk of bias in the studies, we used the revised Cochrane risk-of-bias tools for individually randomized trials (RoB 2) and cluster randomized trials (RoB 2 CRT). After 3.6 years, cash transfers had a small but&amp;nbsp;significant positive effect on cognitive (Cohen’s d  =  0.08, 95% CI 0.04, 0.13), language (d  =  0.09, 95% CI 0.04, 0.13), and gross motor outcomes (d  =  0.07, 95% CI 0.03, 0.11); only conditional cash transfers showed significant effects on socio-emotional...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7pf6q86t</guid>
      <pubDate>Thu, 30 Jul 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Fernald, Lia CH</name>
        <uri>https://orcid.org/0000-0003-1555-4607</uri>
      </author>
      <author>
        <name>Tsai, Eleanor</name>
      </author>
      <author>
        <name>Gertler, Paul J</name>
      </author>
    </item>
    <item>
      <title>Effects of a liquefied petroleum gas stove and fuel intervention and air pollution exposure on early childhood development: Findings from the household air pollution intervention network trial</title>
      <link>https://escholarship.org/uc/item/6p92p697</link>
      <description>BACKGROUND: Early Child Development (ECD) encompasses physical, cognitive, social, and emotional changes during childhood. Air pollution exposure has been associated with ECD delays. The Household Air Pollution Intervention Network (HAPIN) randomized controlled trial evaluated the health effects of a liquefied petroleum gas cookstove and fuel intervention during pregnancy and infancy. Here we present the intervention effect and exposure-response relationship between fine particulate matter (PM&lt;sub&gt;2.5&lt;/sub&gt;) and ECD.
METHODS: The HAPIN trial enrolled 3195 pregnant women in rural Guatemala, Peru, India, and Rwanda. ECD was assessed at 12&amp;nbsp;months of infant age using the Caregiver Reported Early Development Instruments (CREDI). Personal 24-hr PM&lt;sub&gt;2.5&lt;/sub&gt; exposure was measured from baseline through 12&amp;nbsp;months. Linear regression analyses were conducted to evaluate intervention effects on overall and domain-specific CREDI scores and exposure-response relationships between...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6p92p697</guid>
      <pubDate>Thu, 30 Jul 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Thompson, Lisa M</name>
        <uri>https://orcid.org/0000-0002-8001-2057</uri>
      </author>
      <author>
        <name>de León, Oscar</name>
      </author>
      <author>
        <name>Sinharoy, Sheela</name>
      </author>
      <author>
        <name>Valdes, Viviane</name>
      </author>
      <author>
        <name>Das, Seema</name>
      </author>
      <author>
        <name>Aravindalochanan, Vigneswari</name>
      </author>
      <author>
        <name>Pillarisetti, Ajay</name>
      </author>
      <author>
        <name>Jabbarzadeh, Shirin</name>
      </author>
      <author>
        <name>Balakrishnan, Kalpana</name>
      </author>
      <author>
        <name>Diaz-Artiga, Anaite</name>
      </author>
      <author>
        <name>McCracken, John P</name>
      </author>
      <author>
        <name>Rosa, Ghislaine</name>
      </author>
      <author>
        <name>Thangavel, Gurusamy</name>
      </author>
      <author>
        <name>Sambandam, Sankar</name>
      </author>
      <author>
        <name>Mukhopadhyay, Krishnendu</name>
      </author>
      <author>
        <name>Puttaswamy, Naveen</name>
      </author>
      <author>
        <name>Chiang, Marilu</name>
      </author>
      <author>
        <name>Ndagijimana, Florien</name>
      </author>
      <author>
        <name>Lovvorn, Amy E</name>
      </author>
      <author>
        <name>Steenland, Kyle</name>
      </author>
      <author>
        <name>Barr, Dana Boyd</name>
      </author>
      <author>
        <name>Ramakrishnan, Usha</name>
      </author>
      <author>
        <name>Checkley, William</name>
      </author>
      <author>
        <name>Peel, Jennifer</name>
      </author>
      <author>
        <name>Clasen, Thomas</name>
      </author>
      <author>
        <name>investigators, the Household Air Pollution Intervention Network</name>
      </author>
    </item>
    <item>
      <title>Impacts of home-care subsidies: Evidence from quasi-random assignment</title>
      <link>https://escholarship.org/uc/item/67q6t46h</link>
      <description>We study the impact of subsidizing home-based long-term care on recipients’ health and the labor supply of their working-age children. We use administrative data from Israel on the universe of welfare benefit applications linked with tax records of applicants and their adult children. To address the endogeneity of benefit recipients’ health status, we instrument for benefit receipt using the leniency of randomly assigned evaluators who assess the applicant’s functional status and determine benefit eligibility. We find that for compliers—applicants who receive subsidies only from more lenient evaluators—subsidizing home-based care has large adverse effects on recipient health ( + 5.2 p.p. one-year mortality, 95 % CI: 1.5 to 8.9 p.p.) but no detectable effects on their children’s labor market outcomes (child labor market participation: − 0.5 p.p., 95 % CI: − 5.2 to + 4.2 p.p.; child income: − 5.5 log points, 95 % CI: − 46 to + 35 log points). The results are consistent with the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/67q6t46h</guid>
      <pubDate>Wed, 29 Jul 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Ofek-Shanny, Yuval</name>
      </author>
      <author>
        <name>Strulov-Shlain, Avner</name>
      </author>
      <author>
        <name>Zeltzer, Dan</name>
        <uri>https://orcid.org/0000-0002-4140-7531</uri>
      </author>
    </item>
    <item>
      <title>Epidemiology of Intimate Partner Violence</title>
      <link>https://escholarship.org/uc/item/5js361gm</link>
      <description>Abstract Measurement and surveillance of intimate partner violence (IPV) are challenging, and they are critical for understanding IPV as a public health problem, with epidemiological patterns of risk and population-level opportunities for prevention. In the past 2 decades, population-based survey surveillance of IPV has greatly improved in the US and globally. Survey-based surveillance of IPV is complemented by record-based surveillance through criminal justice, health care, and vital statistics systems. In the US, about 45% of adults and 14% of adolescents report experiencing IPV in the Centers for Disease Prevention and Control population-based surveillance surveys, and prevalence varies by race and ethnicity and gender and type of IPV. Epidemiological studies of IPV have also identified risk and protective factors for IPV victimization and perpetration at the individual, interpersonal, community, and societal levels, providing opportunity for prevention. Many policy, practice,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5js361gm</guid>
      <pubDate>Thu, 16 Jul 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Boyce, Sabrina C</name>
        <uri>https://orcid.org/0000-0001-9177-6063</uri>
      </author>
      <author>
        <name>Silverman, Jay G</name>
      </author>
    </item>
    <item>
      <title>Medicaid expansion increased income among newly eligible adults.</title>
      <link>https://escholarship.org/uc/item/8fv3z8tb</link>
      <description>The Affordable Care Acts Medicaid expansion improved health care access for low-income Americans; however, its impact on economic outcomes-particularly income-is less clear. We used US Census administrative income data that tracked 6120 cohorts covering 84% of working-age adults from 2005 to 2019. Using difference-in-differences, we compared changes in income among low-income adults living in expansion states, before and after expansion, with changes in income in low-income adults living in non-expansion states. Low-income adults living in Medicaid-expansion states experienced an average 9.5% relative increase in income in the 5 years after expansion. This impact was concentrated among adults who were likely newly eligible for Medicaid after the expansion. These adults experienced a 9.6% relative increase in income, as well as a 2.1 percentage point (7.3%) relative higher likelihood of having income in the 40th income percentile or higher. We found suggestive evidence that a reduction...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8fv3z8tb</guid>
      <pubDate>Thu, 18 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Chen, Stacy</name>
      </author>
      <author>
        <name>Staiger, Becky</name>
      </author>
    </item>
    <item>
      <title>Early-life Exposure to Punitive School Discipline and Midlife Cognitive Outcomes</title>
      <link>https://escholarship.org/uc/item/1hw8m1x6</link>
      <description>INTRODUCTION: Suspension and expulsion are common in US schools and disproportionately target structurally marginalized children. No research has examined whether these punitive practices may have long-term cognitive-aging implications.
METHODS: In the prospective National Longitudinal Survey of Youth 1979 data (N=8021), we used confounder-adjusted linear models to investigate associations between early-life suspension or expulsion and global cognition, memory, and attention z -scores at age 50. Using interaction terms, we tested for additive scale effect modification by race, gender, and at their intersections.
RESULTS: In all, 21.5% of participants had been suspended and 4.4% expelled, with Black men and women overrepresented among these early-life experiences. Punitive school discipline was associated with lower midlife global cognition, memory, and attention z -scores (eg, global cognition, suspension: : -0.21; 95% CI: -0.26, -0.15; expulsion: :-0.27; 95% CI: -0.38, -0.16)....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1hw8m1x6</guid>
      <pubDate>Thu, 18 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Duarte, Catherine dP</name>
      </author>
      <author>
        <name>Hebert, Jillian</name>
      </author>
      <author>
        <name>Glymour, M Maria</name>
      </author>
      <author>
        <name>Hill-Jarrett, Tanisha G</name>
      </author>
      <author>
        <name>Manly, Jennifer J</name>
      </author>
      <author>
        <name>Mujahid, Mahasin S</name>
        <uri>https://orcid.org/0000-0001-9795-9338</uri>
      </author>
      <author>
        <name>Ahern, Jennifer</name>
      </author>
      <author>
        <name>Yen, Irene H</name>
      </author>
      <author>
        <name>Cohen, Alison K</name>
      </author>
      <author>
        <name>Vable, Anusha M</name>
      </author>
    </item>
    <item>
      <title>Evaluating the impact of a low-cost food storage intervention on complementary food contamination and diarrheal disease in low-income urban households: A randomized controlled trial in Dhaka, Bangladesh.</title>
      <link>https://escholarship.org/uc/item/8tx942q7</link>
      <description>Diarrheal diseases remain a leading cause of under-five mortality globally, yet large-scale water, sanitation, and hygiene (WASH) interventions have shown limited effects on childhood diarrhea and growth, partly because foodborne transmission has been overlooked. In low-income urban settings, complementary foods for young children are often stored for several hours under unsafe conditions, increasing the risk of fecal contamination. This randomized controlled trial evaluated whether a low-cost wire-mesh food cabinet (meatsafe), paired with one-time behavior-change communication (BCC), could reduce microbial contamination and diarrhea among children aged 6-24 months in the Korail informal settlement of Dhaka, Bangladesh. A total of 290 households were randomly assigned 1:1 to receive a meatsafe plus food-hygiene handouts or no intervention. Over five biweekly post-intervention visits, we collected stored complementary food samples (≥4 h) for Escherichia coli testing and recorded...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8tx942q7</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Rahman, Musarrat</name>
      </author>
      <author>
        <name>Nurunnahar, Syeda</name>
      </author>
      <author>
        <name>Akhter, Nazrin</name>
      </author>
      <author>
        <name>Rahman, Mahbubur</name>
      </author>
      <author>
        <name>Amin, Mohammed</name>
      </author>
      <author>
        <name>Haque, Rehnuma</name>
      </author>
      <author>
        <name>Winch, Peter</name>
      </author>
      <author>
        <name>Kwong, Laura</name>
      </author>
    </item>
    <item>
      <title>Hepatitis C and risk of tuberculosis amongst United States veterans: a national cohort study.</title>
      <link>https://escholarship.org/uc/item/2sq9r7bd</link>
      <description>&lt;h4&gt;Background&lt;/h4&gt;Tuberculosis (TB) and hepatitis C virus (HCV) infections share many risk factors and settings. We sought to determine and compare the incidence of TB amongst HCV-positive and negative individuals in a large national cohort of United States veterans, controlling for multiple confounders.&lt;h4&gt;Methods&lt;/h4&gt;We conducted a retrospective-cohort study using data from The Electronically Retrieved Cohort of HCV-Infected Veterans (ERCHIVES) between 2001 and 2024 among United States veterans in care in the Veterans Affairs (VA) healthcare system. HCV-positive veterans were matched to HCV-negative veterans by age, sex, race/ethnicity, and VA enrollment year; veterans with TB diagnosed before the index HCV test, solid organ transplant history, and missing liver fibrosis score (FIB-4) or income data were excluded.&lt;h4&gt;Findings&lt;/h4&gt;The primary outcomes were incident TB, defined as a new diagnosis recorded in the electronic health record after the index HCV antibody test date....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2sq9r7bd</guid>
      <pubDate>Fri, 5 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Malik, Amyn</name>
      </author>
      <author>
        <name>Yan, Peng</name>
      </author>
      <author>
        <name>Belgaumi, Sameer</name>
      </author>
      <author>
        <name>Martinez, Leonardo</name>
      </author>
      <author>
        <name>Shaikh, Obaid</name>
      </author>
      <author>
        <name>Butt, Adeel</name>
      </author>
    </item>
    <item>
      <title>The Long-Term Impact of Early-Life Tuberculosis Disease on Child Health: A Prospective Birth Cohort Study.</title>
      <link>https://escholarship.org/uc/item/1rf5r0gd</link>
      <description>&lt;b&gt;Rationale:&lt;/b&gt; There is growing concern that post-tuberculosis disease (TB) sequelae and morbidity are substantial, but no studies have controlled for preexisting factors before disease. Whether children have post-TB morbidity is not well characterized. &lt;b&gt;Objectives:&lt;/b&gt; To assess the effect of a TB diagnosis on wheezing episodes, lung function, and anthropometric measurements among children enrolled in a prospective birth cohort study in South Africa. &lt;b&gt;Methods:&lt;/b&gt; We prospectively followed children from birth through 5 years for TB using diagnostic tests including chest radiography and repeated induced sputum sample testing with Xpert MTB/RIF and liquid culture. We longitudinally measured health outcomes including growth, wheezing, and lung function up to 5 years. Mixed-effects linear regression models were used to assess growth and lung function after TB. Poisson regression was used to assess risk of subsequent wheezing. &lt;b&gt;Measurements and Main Results:&lt;/b&gt; Among 1,068...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1rf5r0gd</guid>
      <pubDate>Fri, 5 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Martinez, Leo</name>
      </author>
      <author>
        <name>Gray, Diane</name>
      </author>
      <author>
        <name>Botha, Maresa</name>
      </author>
      <author>
        <name>Nel, Michael</name>
      </author>
      <author>
        <name>Chaya, Shaakira</name>
      </author>
      <author>
        <name>Jacobs, Carvern</name>
      </author>
      <author>
        <name>Workman, Lesley</name>
      </author>
      <author>
        <name>Nicol, Mark</name>
      </author>
      <author>
        <name>Zar, Heather</name>
      </author>
    </item>
    <item>
      <title>Dengue transmission risk in California under climate and land-use change: a semi-mechanistic modelling study</title>
      <link>https://escholarship.org/uc/item/6x88x233</link>
      <description>Background Dengue cases are increasing in non-endemic regions due to environmental change and increasing travel and trade. For these non-endemic regions, estimating dengue risk is challenging as transmission is driven by both local environmental conditions and the introduction of viremic travelers. In this study, we aimed to estimate current and future dengue risk in California, USA—a region that has recently experienced its first cases of locally-acquired dengue. Methods We modeled dengue risk as the product of three key components needed for local transmission—vector presence, temperature-suitability for pathogen transmission, and viral introductions via travel-associated cases—estimated using vector and case surveillance, sociodemographic, and environmental data. We estimated risk for locations and months where local transmission was reported in 2023–2024 to define a ‘threshold’ level of risk. We then projected monthly, census tract-level risk under both current conditions...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6x88x233</guid>
      <pubDate>Thu, 4 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Couper, Lisa I</name>
      </author>
      <author>
        <name>Sipin, Terrell J</name>
      </author>
      <author>
        <name>Sambado, Samantha</name>
      </author>
      <author>
        <name>Rennie, Zoe</name>
      </author>
      <author>
        <name>Shanebeck, Kyle M</name>
      </author>
      <author>
        <name>Lyberger, Kelsey P</name>
      </author>
      <author>
        <name>Collender, Philip PA</name>
      </author>
      <author>
        <name>Ngo, Van</name>
      </author>
      <author>
        <name>Remais, Justin V</name>
        <uri>https://orcid.org/0000-0002-0223-4615</uri>
      </author>
      <author>
        <name>MacDonald, Andrew J</name>
        <uri>https://orcid.org/0000-0003-0172-7749</uri>
      </author>
    </item>
    <item>
      <title>The Household Secondary Attack Rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Rapid Review.</title>
      <link>https://escholarship.org/uc/item/6dn0p3sr</link>
      <description>&lt;h4&gt;Background&lt;/h4&gt;Although much of the public health effort to combat coronavirus disease 2019 (COVID-19) has focused on disease control strategies in public settings, transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within households remains an important problem. The nature and determinants of household transmission are poorly understood.&lt;h4&gt;Methods&lt;/h4&gt;To address this gap, we gathered and analyzed data from 22 published and prepublished studies from 10 countries (20 291 household contacts) that were available through 2 September 2020. Our goal was to combine estimates of the SARS-CoV-2 household secondary attack rate (SAR) and to explore variation in estimates of the household SAR.&lt;h4&gt;Results&lt;/h4&gt;The overall pooled random-effects estimate of the household SAR was 17.1% (95% confidence interval [CI], 13.7-21.2%). In study-level, random-effects meta-regressions stratified by testing frequency (1 test, 2 tests, &amp;gt;2 tests), SAR estimates were 9.2%...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6dn0p3sr</guid>
      <pubDate>Thu, 4 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Fung, Hannah</name>
      </author>
      <author>
        <name>Martinez, Leonardo</name>
      </author>
      <author>
        <name>Alarid-Escudero, Fernando</name>
      </author>
      <author>
        <name>Salomon, Joshua</name>
      </author>
      <author>
        <name>Studdert, David</name>
      </author>
      <author>
        <name>Andrews, Jason</name>
      </author>
      <author>
        <name>Goldhaber-Fiebert, Jeremy</name>
      </author>
    </item>
    <item>
      <title>A Cluster of Novel Coronavirus Disease 2019 Infections Indicating Person-to-Person Transmission Among Casual Contacts From Social Gatherings: An Outbreak Case-Contact Investigation.</title>
      <link>https://escholarship.org/uc/item/2600p9mp</link>
      <description>&lt;h4&gt;Background&lt;/h4&gt;Severe acute respiratory syndrome coronavirus 2, the pathogen causing novel coronavirus disease of 2019 (COVID-19), efficiently spreads from person to person in close contact settings. Transmission among casual contacts in settings such as during social gatherings is not well understood.&lt;h4&gt;Methods&lt;/h4&gt;We report several transmission events to both close and casual contacts from a cluster of 7 COVID-19 cases occurring from mid-January to early February 2020. A total of 539 social and family contacts of the index patients, including members of a 2-day wedding and a family party, were contacted and screened through epidemiologic surveys. The clinical progression of all cases is described.&lt;h4&gt;Results&lt;/h4&gt;We estimate the secondary attack rate among close contacts to be 29% (2 of 7) and for the casual contacts to be 0.6% (3 of 473). The incubation period of our case cluster was 4-12 days (median, 7 days).&lt;h4&gt;Conclusions&lt;/h4&gt;Transmission efficiency among close contacts...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2600p9mp</guid>
      <pubDate>Thu, 4 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Shen, Ye</name>
      </author>
      <author>
        <name>Xu, Wenjie</name>
      </author>
      <author>
        <name>Li, Changwei</name>
      </author>
      <author>
        <name>Handel, Andreas</name>
      </author>
      <author>
        <name>Martinez, Leo</name>
      </author>
      <author>
        <name>Ling, Feng</name>
      </author>
      <author>
        <name>Ebell, Mark</name>
      </author>
      <author>
        <name>Fu, Xiaofei</name>
      </author>
      <author>
        <name>Pan, Jinren</name>
      </author>
      <author>
        <name>Ren, Jiangping</name>
      </author>
      <author>
        <name>Gu, Weiling</name>
      </author>
      <author>
        <name>Chen, Enfu</name>
      </author>
    </item>
    <item>
      <title>Trends in medical debt in the United States by imputed borrower race and ethnicity, 2016-2022.</title>
      <link>https://escholarship.org/uc/item/0c3354wr</link>
      <description>&lt;h4&gt;Introduction&lt;/h4&gt;Medical debt is a major financial consequence of healthcare in the United States, but there is limited evidence about whether medical debt in collections varies across racial and ethnic groups.&lt;h4&gt;Methods&lt;/h4&gt;We analyzed credit report data from 2016 to 2022 for 23,093,888 adults to study medical debt in collections accrued within the past year (flow) and total outstanding medical debt in collections (stock).&lt;h4&gt;Results&lt;/h4&gt;Black borrowers had the highest levels of annual flow of medical debt, with 11.2% of borrowers facing any annual flow of debt in 2022 (mean conditional on any flow: $1524). Similar trends existed for stock, with 24% of borrowers having any stock in 2022 (mean conditional on any stock: $2074). Hispanic and White borrowers had similar medical debt, and Asian and Pacific Islander borrowers had the least debt. Gaps between racial and ethnic groups were smaller in states that expanded Medicaid compared to those that did not, especially on the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0c3354wr</guid>
      <pubDate>Thu, 4 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Adia, Alexander C</name>
      </author>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
      <author>
        <name>Hsuan, Charleen</name>
        <uri>https://orcid.org/0000-0001-8720-2323</uri>
      </author>
      <author>
        <name>Rodriguez, Hector P</name>
        <uri>https://orcid.org/0000-0002-6564-2229</uri>
      </author>
    </item>
    <item>
      <title>Revitalizing the US Youth Presidential Fitness Test: Are States Prepared to Support Implementation?</title>
      <link>https://escholarship.org/uc/item/7rf9h326</link>
      <description>Our objective was to describe policy infrastructure of elementary school fitness testing at the state level and to assess states readiness for implementation of the recently reinstated Presidential Fitness Test. We conducted a cross-sectional policy analysis by using data from the State of the States Policy Report and used the Classification of Laws Associated with School Students to create a standardized readiness index. Only 5 states required recommended weekly minutes of physical education, 24 had no fitness testing requirements, 6 mandated testing results reporting, and most delegated compliance monitoring locally. State policies are not positioned to support large-scale standardized fitness testing, indicating a need for coordinated reform.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7rf9h326</guid>
      <pubDate>Mon, 1 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Killian, Chad</name>
      </author>
      <author>
        <name>DAgostino, Emily</name>
      </author>
      <author>
        <name>Kern, Ben</name>
      </author>
      <author>
        <name>Kim, Christina</name>
      </author>
      <author>
        <name>King, Devon</name>
      </author>
      <author>
        <name>Albeke, Shannan</name>
      </author>
      <author>
        <name>Thompson, Hannah</name>
      </author>
    </item>
    <item>
      <title>Increasing Divergence in Drug Prices Between the United States and Germany After Implementation of Comparative Effectiveness Analysis and Collective Price Negotiations.</title>
      <link>https://escholarship.org/uc/item/8nk9k5t3</link>
      <description>BACKGROUND: Payers and purchasers in the United States seek to moderate drug prices and align them with the incremental clinical benefit offered by individual medications; some policymakers have proposed linking U.S. prices to an index of prices paid in other nations. The German health care system resembles that of the United States in featuring multiple private payers but differs in featuring a highly coordinated process of comparative clinical assessment and price negotiations for drugs.
OBJECTIVES: To (a) measure trends in prices paid for physician-administered drugs in Germany before and after the mandate for comparative effectiveness assessment and price negotiations in 2011 and (b) compare them with price trends for the same drugs in the United States.
METHODS: This study observed trends in the prices paid for 80 physician-administered drugs, which account for approximately half of Medicare Part B drug spending. Quarterly data covering 2004-2018 were obtained for Germany...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8nk9k5t3</guid>
      <pubDate>Mon, 25 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Berkemeier, Fabian</name>
      </author>
      <author>
        <name>Whaley, Christopher</name>
      </author>
      <author>
        <name>Robinson, James C</name>
      </author>
    </item>
    <item>
      <title>Association of Reference Pricing for Diagnostic Laboratory Testing With Changes in Patient Choices, Prices, and Total Spending for Diagnostic Tests</title>
      <link>https://escholarship.org/uc/item/8dj8k2hw</link>
      <description>IMPORTANCE: Prices for laboratory and other clinical services vary widely. Employers and insurers increasingly are adopting "reference pricing" policies to create incentives for patients to select lower-priced facilities.
OBJECTIVE: To measure the association between implementation of reference pricing and patient choice of laboratory, test prices, patient out-of-pocket spending, and insurer spending.
DESIGN, SETTING, AND PARTICIPANTS: We conducted an observational study of changes in laboratory pricing and selection by employees of a large national grocery firm (n = 30 415) before and after the firm implemented a reference pricing policy for laboratory services and compared the findings with changes over the same period for policy holders of a large national insurer that did not implement reference pricing (n = 181 831). The grocery firm established a maximum payment limit at the 60th percentile of the distribution of prices for each laboratory test in each region. Employees...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8dj8k2hw</guid>
      <pubDate>Mon, 25 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
      <author>
        <name>Whaley, Christopher</name>
      </author>
      <author>
        <name>Brown, Timothy T</name>
        <uri>https://orcid.org/0000-0002-5334-0768</uri>
      </author>
    </item>
    <item>
      <title>Medicare Advantage Reimbursement to Physicians</title>
      <link>https://escholarship.org/uc/item/7xc1w9k5</link>
      <description>Medicare Advantage Reimbursement to Physicians</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7xc1w9k5</guid>
      <pubDate>Mon, 25 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
    </item>
    <item>
      <title>Consumer Choice Between Hospital-Based and Freestanding Facilities for Arthroscopy</title>
      <link>https://escholarship.org/uc/item/7nw952wq</link>
      <description>BACKGROUND: Hospital-based outpatient departments traditionally charge higher prices for ambulatory procedures, compared with freestanding surgery centers. Under emerging reference-based benefit designs, insurers establish a contribution limit that they will pay, requiring the patient to pay the difference between that contribution limit and the actual price charged by the facility. The purpose of this study was to evaluate the impact of reference-based benefits on consumer choices, facility prices, employer spending, and surgical outcomes for orthopaedic procedures performed at ambulatory surgery centers.
METHODS: We obtained data on 3962 patients covered by the California Public Employees' Retirement System (CalPERS) who underwent arthroscopy of the knee or shoulder in the three years prior to the implementation of reference-based benefits in January 2012 and on 2505 patients covered by CalPERS who underwent arthroscopy in the two years after implementation. Control group data...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7nw952wq</guid>
      <pubDate>Mon, 25 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
      <author>
        <name>Brown, Timothy T</name>
        <uri>https://orcid.org/0000-0002-5334-0768</uri>
      </author>
      <author>
        <name>Whaley, Christopher</name>
      </author>
      <author>
        <name>Bozic, Kevin J</name>
      </author>
    </item>
    <item>
      <title>Value-Based Pricing and Patient Access for Specialty Drugs</title>
      <link>https://escholarship.org/uc/item/6kx656sp</link>
      <description>Value-Based Pricing and Patient Access for Specialty Drugs</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6kx656sp</guid>
      <pubDate>Mon, 25 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
      <author>
        <name>Howell, Scott</name>
      </author>
      <author>
        <name>Pearson, Steven D</name>
      </author>
    </item>
    <item>
      <title>Reference Pricing, Consumer Cost-Sharing, and Insurer Spending for Advanced Imaging Tests</title>
      <link>https://escholarship.org/uc/item/6bp9x901</link>
      <description>BACKGROUND: Fees charged for similar imaging tests often vary dramatically within the same market, leading to wide variation in insurer spending and consumer cost-sharing. Reference pricing is an insurance design that offers good coverage to patients up to a defined contribution limit but requires the patients who select high-priced facilities to pay the remainder out of pocket.
OBJECTIVES: To measure the association between implementation of reference pricing and patient choice of facility, test prices, out-of-pocket spending, and insurer spending for advanced imaging (CT and MRI) procedures.
RESEARCH DESIGN: Difference-in-differences multivariable analysis of insurance claims data. Study included 4751 employees of a national grocery chain (treatment group) and 23,428 enrollees in the nation's largest private insurance plan (comparison group) that used CT or MRI tests between 2010 and 2013.
MEASURES: Patient choice of facility, price paid per test, patient out-of-pocket cost-sharing,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6bp9x901</guid>
      <pubDate>Mon, 25 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
      <author>
        <name>Whaley, Christopher</name>
      </author>
      <author>
        <name>Brown, Timothy T</name>
        <uri>https://orcid.org/0000-0002-5334-0768</uri>
      </author>
    </item>
    <item>
      <title>Value‐Based Physician Payment in Oncology: Public and Private Insurer Initiatives</title>
      <link>https://escholarship.org/uc/item/5br9x355</link>
      <description>Policy Points:     Public and private insurers are implementing payment mechanisms to improve coordination and reduce the cost of drug, hospital, and ancillary services for cancer patients. Some target unnecessary hospitalization, while others create incentives for prescribing lower‐cost chemotherapies and biologics.   Physician payment methods in oncology require a balance between incentives for cost control and incentives for patient access to expensive specialty drugs.   None of the initiatives adopt bundled methods out of concern for shifting excessive financial risk onto physicians in the context of rapid pharmaceutical innovation.        Context High‐value oncology requires physicians to monitor and coordinate all aspects of care, educate and engage their patients, and adopt cost‐effective drug treatments. However, oncology practices in the United States traditionally have been reimbursed based on the number of office visits performed and through cost‐plus margins from prescription...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5br9x355</guid>
      <pubDate>Mon, 25 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>ROBINSON, JAMES C</name>
      </author>
    </item>
    <item>
      <title>Value-based payment for oncology services in the United States and France</title>
      <link>https://escholarship.org/uc/item/1zj2r1xb</link>
      <description>The pursuit of economic and clinical value in oncology goes “beyond the pill” to encompass improvements in the process of caring for patients suffering from cancer. The concept of value-based payment thus extends beyond the amounts reimbursed for drugs themselves to encompass the methods of payment used for the physicians and facilities where those drugs are prescribed and delivered. Oncology payment mechanisms vary widely across nations depending on the structure of their health care systems, but the challenges of appropriate drug selection and patient engagement are common to all. This paper describes contemporary efforts to create stronger payment incentives for appropriate drug selection, administration, monitoring, and management in the United States and France.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1zj2r1xb</guid>
      <pubDate>Mon, 25 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
      <author>
        <name>Megerlin, Francis</name>
      </author>
    </item>
    <item>
      <title>Association of Reference Pricing with Drug Selection and Spending</title>
      <link>https://escholarship.org/uc/item/1jr0g6gf</link>
      <description>Background In the United States, prices for therapeutically similar drugs vary widely, which has prompted efforts by public and private insurers to steer patients toward the lower-priced options. Under reference pricing, the insurer or employer establishes a maximum contribution it will make toward the price of a drug or procedure, and the patient pays the remainder. Methods We used difference-in-differences multivariable regression methods to analyze changes in prescriptions and pricing for 1302 drugs in 78 therapeutic classes in the United States, before and after implementation of reference pricing by an alliance of private employers. We assessed trends for the study group relative to those for an employee group that was not subject to reference pricing. The study included 1,122,741 prescriptions that were reimbursed during the period from 2010 through 2014. Results Implementation of reference pricing was associated with a higher percentage of prescriptions that were filled...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1jr0g6gf</guid>
      <pubDate>Mon, 25 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
      <author>
        <name>Whaley, Christopher M</name>
      </author>
      <author>
        <name>Brown, Timothy T</name>
        <uri>https://orcid.org/0000-0002-5334-0768</uri>
      </author>
    </item>
    <item>
      <title>Consumer Responses to Price Transparency Alone versus Price Transparency Combined with Reference Pricing</title>
      <link>https://escholarship.org/uc/item/0s14v776</link>
      <description>Efforts to spur patient price shopping by providing access to price transparency tools have been met with limited success. One potential reason is the absence of financial incentives. This paper uses data from a large employer that implemented a price transparency platform and subsequently implemented a reference pricing program for laboratory and diagnostic imaging tests. We find no price shopping effects when the price transparency tool is offered alone. However, combining price transparency with reference pricing leads to significant shifts in consumer choice of facility, resulting in a 27 percent reduction in the average price paid per laboratory test and a 13 percent reduction in price paid per imaging test. A variety of public and purchaser initiatives have sought to further the development and adoption of price transparency tools. Our results imply that these tools will capture the attention of consumers, and influence their behavior, only if patients have strong financial...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0s14v776</guid>
      <pubDate>Mon, 25 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Whaley, Christopher</name>
      </author>
      <author>
        <name>Brown, Timothy</name>
      </author>
      <author>
        <name>Robinson, James</name>
      </author>
    </item>
    <item>
      <title>The Redesign of Consumer Cost Sharing for Specialty Drugs at the California Health Insurance Exchange</title>
      <link>https://escholarship.org/uc/item/0hb2794m</link>
      <description>This paper describes the redesign of health benefits at Covered California-the nation's largest health insurance exchange, which covers 1.3 million individuals, and its benefit designs extending to hundreds of thousands more enrollees through insurance products sold outside the exchange-with respect to specialty drugs for the 2016 enrollment year. The catalyst for benefit redesign came from advocacy organizations representing patients suffering from HIV, multiple sclerosis, epilepsy, hepatitis C, and other chronic conditions. The first component of the benefit redesign creates a separate deductible for pharmaceutical expenditures, with a commensurate reduction in the deductible for other (medical) expenditures. The second component requires health plans to assign at least 1 specialty drug for each therapeutic class to a nonspecialty tier, offering patients a treatment option for which they are not exposed to coinsurance. The third component imposes a monthly payment limit of $250...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0hb2794m</guid>
      <pubDate>Mon, 25 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James</name>
      </author>
      <author>
        <name>Price, Anne</name>
      </author>
      <author>
        <name>Goldman, Zachary</name>
      </author>
    </item>
    <item>
      <title>Quantifying The Economic Burden Of Drug Utilization Management On Payers, Manufacturers, Physicians, And Patients</title>
      <link>https://escholarship.org/uc/item/99w3k5t2</link>
      <description>The continuing launch of innovative but high-price drugs has intensified efforts by payers to manage use and spending and by pharmaceutical manufacturers to support patient access and sales. Payers are restricting drug formularies, requiring more stringent prior authorizations, and raising patient cost-sharing requirements. Manufacturers are investing in programs that help patients and physician practices navigate administrative controls and help patients meet cost-sharing obligations. Based on a compilation and analysis of the existing peer-reviewed and professional literature, this article estimates that payers, manufacturers, physicians, and patients together incur approximately $93.3&amp;nbsp;billion in costs annually on implementing, contesting, and navigating utilization management. Payers spend approximately $6.0&amp;nbsp;billion annually administering drug utilization management, and manufacturers spend approximately $24.8&amp;nbsp;billion supporting patient access in response. Physicians...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/99w3k5t2</guid>
      <pubDate>Sat, 23 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Howell, Scott</name>
      </author>
      <author>
        <name>Yin, Perry T</name>
      </author>
      <author>
        <name>Robinson, James C</name>
      </author>
    </item>
    <item>
      <title>Drug Pricing With Evidence Development</title>
      <link>https://escholarship.org/uc/item/8rm280fm</link>
      <description>This Viewpoint describes pricing with evidence development whereby the price of a drug evolves in accordance with the evidence of its clinical benefit.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8rm280fm</guid>
      <pubDate>Sat, 23 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
    </item>
    <item>
      <title>Penetration rate of anti-TNF biosimilars and savings at 5 years after their introduction in French hospitals</title>
      <link>https://escholarship.org/uc/item/7jv0q6v0</link>
      <description>OBJECTIVE: Since the expiry of the patents on originator anti-TNF agents in Europe, France has authorized the sale of biosimilars. The penetration rate of anti-TNF agents and their biosimilars, and the cost savings driven by the introduction of biosimilars appears to vary widely. This study aimed to describe the market share of anti-TNFs and their biosimilars, and the cost savings generated by the introduction of biosimilars in French hospitals 5 years ago.
METHODS: The pharmaceutical component of the French national uniform hospital discharge data set database (PMSI) was used to study sales of infliximab, etanercept and adalimumab originators and biosimilars, and to estimate cost savings generated by the introduction of biosimilars onto the market, using the historical tariffs of the originators.
RESULTS: The penetration rate of anti-TNF biosimilars in France in 76% for infliximab, 74% for etanercept and 77% for adalimumab. In 2020, Inflectra® (41%) was the Remicade® biosimilar...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7jv0q6v0</guid>
      <pubDate>Sat, 23 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Jarrion, Quentin</name>
      </author>
      <author>
        <name>Azzouz, Brahim</name>
      </author>
      <author>
        <name>Robinson, James</name>
      </author>
      <author>
        <name>Jolly, Damien</name>
      </author>
      <author>
        <name>Vallet, Catherine</name>
      </author>
      <author>
        <name>Trenque, Thierry</name>
      </author>
    </item>
    <item>
      <title>Why Is Aducanumab Priced at $56,000 per Patient? Lessons for Drug-Pricing Reform</title>
      <link>https://escholarship.org/uc/item/7642733x</link>
      <description>Why Is Aducanumab Priced at $56,000 per Patient? Aducanumab’s price can inform the drug-pricing policy debate because it responds to key features of the market environment for physician-administere...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7642733x</guid>
      <pubDate>Sat, 23 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
    </item>
    <item>
      <title>In (Faint) Praise of Pharmaceutical Import Tariffs</title>
      <link>https://escholarship.org/uc/item/70s007cc</link>
      <description>This Viewpoint discusses the reasons that drug manufacturing is leaving the US; highlights the weaknesses of tariffs as currently implemented for bringing it back; and calls for the moderate implementation of tariffs as one component of industrial policy and the reinvestment of tariff revenues in pharmaceutical innovation.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/70s007cc</guid>
      <pubDate>Sat, 23 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
    </item>
    <item>
      <title>Hospital Adoption and Pricing for Oncology Biosimilars</title>
      <link>https://escholarship.org/uc/item/6vn6j72q</link>
      <description>Importance: Many physician-administered oncology biologics are losing patent protection in the coming years and will face competition from biosimilars. Hospitals and insurers share a mutual interest in developing payment methods that share the potential savings from adopting these less costly agents.
Objective: To test whether hospitals paid lower acquisition prices and earned higher markup margins for physician-administered oncology biosimilars; whether insurers reduced the reimbursement prices they paid to hospitals, thereby sharing in the savings from lower manufacturer prices; and whether reductions in acquisition prices and increases in hospital margins were associated with accelerated adoption of biosimilars.
Design, Setting, and Participants: Observational study using 2020-2024 data for patients covered by Blue Cross Blue Shield health insurance, linked to information on drug acquisition prices paid by hospitals to manufacturers; drug reimbursement prices paid by insurers...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6vn6j72q</guid>
      <pubDate>Sat, 23 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
      <author>
        <name>Kosorukov, Ari D</name>
      </author>
      <author>
        <name>Whaley, Christopher M</name>
      </author>
    </item>
    <item>
      <title>Lower Prices and Greater Patient Access — Lessons from Germany’s Drug-Purchasing Structure</title>
      <link>https://escholarship.org/uc/item/6hm8p2q5</link>
      <description>Lower Prices and Greater Patient Access The German system for determining drug prices features collective negotiations on the part of competing health plans. It also creates incentives for agreemen...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6hm8p2q5</guid>
      <pubDate>Sat, 23 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
    </item>
    <item>
      <title>Drug Pricing, Competition, And Regulation: The Authors Reply</title>
      <link>https://escholarship.org/uc/item/6cb1g6nw</link>
      <description>Drug Pricing, Competition, And Regulation: The Authors Reply</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6cb1g6nw</guid>
      <pubDate>Sat, 23 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
      <author>
        <name>Jarrion, Quentin</name>
      </author>
    </item>
    <item>
      <title>Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic</title>
      <link>https://escholarship.org/uc/item/52n4g1z6</link>
      <description>This Viewpoint considers whether the shift away from private investment toward government funding of drug and vaccine development and commercialization during the coronavirus disease 2019 (COVID-19) pandemic is sustainable, arguing that the same or greater level of public investment will be necessary if drug prices are to remain affordable and if the US wants to maintain its global leadership position.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/52n4g1z6</guid>
      <pubDate>Sat, 23 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
    </item>
    <item>
      <title>Pharmacy Benefit Management: The Cost of Drug Price Rebates.</title>
      <link>https://escholarship.org/uc/item/49s301k7</link>
      <description>Pharmacy Benefit Managers (PBM) induce drug manufacturers to offer rebates to insurers and employers by denying coverage through formulary exclusions, impeding physician prescription through prior authorization, and reducing patient drug use through cost sharing. As they tighten these access obstacles, PBMs reduce the net prices received by the manufacturers.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/49s301k7</guid>
      <pubDate>Sat, 23 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
    </item>
    <item>
      <title>Social trust and regional variation in the adoption of biosimilars in Italy and Germany</title>
      <link>https://escholarship.org/uc/item/32q9739s</link>
      <description>Introduction/Study Objectives: Adoption of biosimilars has fallen below projections, despite the vigorous implementation of economic incentives, thereby highlighting the importance of behavioural factors such as social trust. This paper analyses biosimilar adoption across provinces in Italy and Germany, which evince strong variation in social trust, and across nations in Europe. Methods: Data for 2020 biosimilar adoption for Italian provinces were obtained from the national pharmaceutical organization and for German states from the association of biosimilar manufacturers. Social trust was coded for Italy and Germany using historical metrics; political trust was coded using the Quality of Government Index (QGI). Multivariable methods were used to ascertain the association between adoption, social trust, political trust, and income per capita. Regressions also were conducted using data at the national level for 20 European nations. The study includes two biologicals for chronic...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/32q9739s</guid>
      <pubDate>Sat, 23 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
    </item>
    <item>
      <title>Hospital Prices for Physician-Administered Drugs for Patients with Private Insurance</title>
      <link>https://escholarship.org/uc/item/2xt4z35w</link>
      <description>BACKGROUND: Hospitals can leverage their position between the ultimate buyers and sellers of drugs to retain a substantial share of insurer pharmaceutical expenditures.
METHODS: In this study, we used 2020-2021 national Blue Cross Blue Shield claims data regarding patients in the United States who had drug-infusion visits for oncologic conditions, inflammatory conditions, or blood-cell deficiency disorders. Markups of the reimbursement prices were measured in terms of amounts paid by Blue Cross Blue Shield plans to hospitals and physician practices relative to the amounts paid by these providers to drug manufacturers. Acquisition-price reductions in hospital payments to drug manufacturers were measured in terms of discounts under the federal 340B Drug Pricing Program. We estimated the percentage of Blue Cross Blue Shield drug spending that was received by drug manufacturers and the percentage retained by provider organizations.
RESULTS: The study included 404,443 patients in the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2xt4z35w</guid>
      <pubDate>Sat, 23 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
      <author>
        <name>Whaley, Christopher</name>
      </author>
      <author>
        <name>Dhruva, Sanket S</name>
      </author>
    </item>
    <item>
      <title>Pricing of Drugs With Evidence Development—Reply</title>
      <link>https://escholarship.org/uc/item/1bq1r603</link>
      <description>Pricing of Drugs With Evidence Development—Reply</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1bq1r603</guid>
      <pubDate>Sat, 23 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
    </item>
    <item>
      <title>Sophisticated Purchasing of Pharmaceuticals</title>
      <link>https://escholarship.org/uc/item/01s094g3</link>
      <description>Sophisticated Purchasing of Pharmaceuticals</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/01s094g3</guid>
      <pubDate>Sat, 23 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
    </item>
    <item>
      <title>Small is Not Beautiful: A Critique of Antitrust Economics and Policy in Health Care</title>
      <link>https://escholarship.org/uc/item/9fv6g6zm</link>
      <description>The dominant health policy perspective today appears to be that markets are over-consolidated and in need of anti-trust intervention. This commentary argues that the diagnosis is largely incorrect and the proposed treatment ineffective or, worse, effective but undesirable. The anti-trust ideal of a fragmented cottage industry of physician practices, hospitals, and other care organizations does not promise efficiency, even if the current industry configuration also is far from ideal. Many health care market are indeed competitive, and most are contestable, when one views provider organizations as multiproduct firms competing in overlapping geographic and customer markets. For example, many hospital systems compete in overlapping markets for primary care, specialty procedures, drug infusion, home health, subacute care, transplant surgery, telemedicine, population health management, and other services beyond traditional acute inpatient care. The anti-trust perspective should articulate...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9fv6g6zm</guid>
      <pubDate>Fri, 22 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Robinson, James C</name>
      </author>
    </item>
    <item>
      <title>Do conditional marketing authorisations actually accelerate patient access? Time-to-access of conditional vs. standard marketing authorisations in Italy, Spain, and Germany</title>
      <link>https://escholarship.org/uc/item/83h1t9v5</link>
      <description>Background: The European Medicines Agency (EMA) implemented 'fast-track' programmes, like conditional marketing authorisations (CMA), where the benefits of immediate drugs' availability outweigh the risks associated with incomplete evidence. However, payers in the European Union (EU) decide on medicines' coverage based on clinical benefits assessment, cost-effectiveness and/or budget impact. We investigated differences in the time-to-access of drugs approved via CMA vis-à-vis standard marketing authorisation (SMA) in Italy, Germany, and Spain.
Methods: CMA-licenced drugs from 2006 to 2022 were retrieved and matched with comparable SMA drugs. Collected data were as follows: marketing authorisation details, drug characteristics, pivotal trials' characteristics and national reimbursement decision dates. Data sources included European Public Assessment Reports, and country-specific databases (Farmadati®, Lauer-Taxe®, BIFIMED).
Results: CMA drugs take longer, in days, to reach reimbursement...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/83h1t9v5</guid>
      <pubDate>Fri, 22 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Ardito, Vittoria</name>
      </author>
      <author>
        <name>Falk, Lasse</name>
      </author>
      <author>
        <name>Boncompte, Montserrat Gasol</name>
      </author>
      <author>
        <name>Pontes, Caridad</name>
      </author>
      <author>
        <name>Robinson, James</name>
      </author>
      <author>
        <name>Schreyögg, Jonas</name>
      </author>
      <author>
        <name>Ciani, Oriana</name>
      </author>
    </item>
    <item>
      <title>Innovation Culture Declines Drive Exnovation of Patient Engagement Strategies in Primary Care.</title>
      <link>https://escholarship.org/uc/item/8779v4q7</link>
      <description>Patient engagement strategies (PES) are behavioral and relational in nature. They include using patient-reported outcomes (PROs) for treatment monitoring, using shared decision-making (SDM) tools, and training clinicians in motivational interviewing. The long-term maintenance of PES by primary care practices requires substantial frontline effort, adaptation to workflow, and supportive organizational cultures. To measure the adoption and exnovation of PES by adult primary care practices and to identify organizational factors associated with the count of exnovated PES, defined as the deliberate or passive removal of previously adopted strategies. Retrospective longitudinal cohort study. A national cohort of US adult primary care physician practices (n = 714), spanning two waves of the National Survey of Healthcare Organizations and Systems (NSHOS I: 2017-2018 and NSHOS II: 2022-2023). The outcome was the number of PES that the practice exnovated, on net. Independent variables included...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8779v4q7</guid>
      <pubDate>Thu, 21 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Rodriguez, Hector P</name>
        <uri>https://orcid.org/0000-0002-6564-2229</uri>
      </author>
      <author>
        <name>Mackwood, Matthew B</name>
      </author>
      <author>
        <name>Shortell, Stephen M</name>
      </author>
      <author>
        <name>Fisher, Elliott S</name>
      </author>
      <author>
        <name>Schifferdecker, Karen E</name>
      </author>
    </item>
    <item>
      <title>U.S. Primary Care Practice Capabilities Linked to Language Services for Patients with Limited English Proficiency</title>
      <link>https://escholarship.org/uc/item/5xb3973g</link>
      <description>BackgroundPatients with limited English proficiency (LEP) experience more challenges with clinician communication than English-proficient patients. U.S. federal policies require the provision of language services, but little is known about language service availability in adult primary care practices nationally.ObjectiveTo identify primary care physician practice capabilities associated with the routine availability of language services for patients with LEP.DesignNationally representative physician practice survey data from the National Survey of Healthcare Organizations and Systems were linked to IQVIA OneKey data and the American Community Survey (n = 1226). Multivariable logistic regression models were estimated to assess the association of practice characteristics with availability of language services.Main MeasuresWhether a practice “always” provides professional language services.
Key ResultsFifty-four percent of U.S. primary care practices always provide language services....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5xb3973g</guid>
      <pubDate>Thu, 21 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Chen, Stacy</name>
      </author>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
      <author>
        <name>Rodriguez, Hector P</name>
        <uri>https://orcid.org/0000-0002-6564-2229</uri>
      </author>
      <author>
        <name>Schifferdecker, Karen E</name>
      </author>
    </item>
    <item>
      <title>Changes in Dietary Supplement Use Among Children and Adolescents in the United States, 2015–2016 to 2021–2023</title>
      <link>https://escholarship.org/uc/item/7sm6b6jq</link>
      <description>Changes in Dietary Supplement Use Among Children and Adolescents in the United States, 2015–2016 to 2021–2023</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7sm6b6jq</guid>
      <pubDate>Wed, 6 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Recio, Brandy</name>
      </author>
      <author>
        <name>Li, Qingrong Jessica</name>
      </author>
      <author>
        <name>Guadamuz, Jenny</name>
      </author>
      <author>
        <name>Qato, Dima Mazen</name>
      </author>
    </item>
    <item>
      <title>Respirable Aerosol Production and Reduction of Avian Influenza Transmission Risk during Chicken Processing, Bangladesh.</title>
      <link>https://escholarship.org/uc/item/7097f8mt</link>
      <description>In Bangladesh, influenza A(H5N1) viruses are endemic in poultry. Processing infected chickens can aerosolize viruses, increasing the risk for human infections. We evaluated particulate matter (PM&lt;sub&gt;2.5&lt;/sub&gt;) mass concentration during slaughtering and defeathering methods used in live bird markets in Bangladesh to identify solutions to reduce aerosol exposure. We slaughtered 675 chickens using cones and barrels with 3 lid types and defeathered 45 chickens using a defeathering machine with 5 lid types. We interviewed 3 slaughterers to understand method preference. For slaughtering, barrels with a solid or star-cut lid reduced PM&lt;sub&gt;2.5&lt;/sub&gt; mass concentrations by 65%-73% compared with uncovered barrels. For defeathering, machines fully covered by a solid lid or lid with a hole and pivot door reduced PM&lt;sub&gt;2.5&lt;/sub&gt; mass concentrations by 50% compared with machines with no lid. Slaughterers preferred barrels covered with solid lids and defeathering machines covered with solid...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7097f8mt</guid>
      <pubDate>Thu, 30 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Rimi, Nadia</name>
      </author>
      <author>
        <name>Saifullah, Md</name>
      </author>
      <author>
        <name>Fahad, Md</name>
      </author>
      <author>
        <name>Hossain, Kamal</name>
      </author>
      <author>
        <name>Sultana, Rebeca</name>
      </author>
      <author>
        <name>Shanta, Ireen</name>
      </author>
      <author>
        <name>Swayne, David</name>
      </author>
      <author>
        <name>Mortaza, Syed</name>
      </author>
      <author>
        <name>Giasuddin, Md</name>
      </author>
      <author>
        <name>Hassan, Md</name>
      </author>
      <author>
        <name>LeBoa, Christopher</name>
      </author>
      <author>
        <name>Biswas, Debashish</name>
      </author>
      <author>
        <name>Rahman, Mahbubur</name>
      </author>
      <author>
        <name>Mott, Joshua</name>
      </author>
      <author>
        <name>Kennedy, Erin</name>
      </author>
      <author>
        <name>Lindsley, William</name>
      </author>
    </item>
    <item>
      <title>Community violence intervention: measuring risk &amp;amp; protective factors for gun use among program participants</title>
      <link>https://escholarship.org/uc/item/9gg7x7bd</link>
      <description>Community Violence Intervention (CVI) involves recruiting likely gun violence offenders using street outreach and offering mentorship, social services and other supports to discourage future firearm violence. Grounded in public health, CVI interventions identify an individual’s risk factors and work to enhance protective and buffering factors that can help prevent a client from offending. This paper reviews evaluations of CVI interventions to understand how participants’ risk factors are defined and measured. We used keywords to identify 38 published evaluations of 32 different CVI interventions that recruited community members and used street-outreach as the primary mode of engagement. We then used the PRISMA scoping review methodology to identify categories of risk and protective factors to screen each published evaluation for whether and how they measured participants’ risk, protective and buffering factors at program onset. We found that 56% (18/32) of evaluations included...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9gg7x7bd</guid>
      <pubDate>Wed, 22 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Corburn, Jason</name>
      </author>
      <author>
        <name>Bruno, Alice</name>
      </author>
      <author>
        <name>Cabrera, Juan</name>
      </author>
      <author>
        <name>Darling-Hammond, Sean</name>
        <uri>https://orcid.org/0000-0002-6353-4670</uri>
      </author>
      <author>
        <name>Mujahid, Mahasin</name>
        <uri>https://orcid.org/0000-0001-9795-9338</uri>
      </author>
    </item>
    <item>
      <title>Investigating the zoonotic origins of ESBL-producing E. coli in community-acquired urinary tract infections in Ecuador.</title>
      <link>https://escholarship.org/uc/item/8b1735q6</link>
      <description>Extended-spectrum β-lactamase-producing &lt;i&gt;Escherichia coli&lt;/i&gt; (ESBL-producing &lt;i&gt;E. coli&lt;/i&gt;) pose a growing global health threat. Although Latin America has been identified as a global hotspot of antimicrobial resistance, the zoonotic contribution to drug-resistant infections in the region remains poorly defined. We analyzed 137 clinical ESBL-producing &lt;i&gt;E. coli&lt;/i&gt; isolates from urinary tract infections (UTIs) in Quito, Ecuador, applying a Bayesian latent class model informed by host-associated mobile genetic elements to estimate the fraction of infections attributable to food-animal sources. We estimated that 25.5% (35/137) of UTI isolates were putative zoonotic cases. This proportion rose to 42.5% after excluding ST131-&lt;i&gt;H&lt;/i&gt;30, a human-associated pandemic lineage. Putative zoonotic isolates were enriched for animal-associated β-lactamase genes (e.g., &lt;i&gt;bla&lt;/i&gt;&lt;sub&gt;TEM-1B&lt;/sub&gt;&lt;i&gt;, bla&lt;/i&gt;&lt;sub&gt;CTX-M-65&lt;/sub&gt;), lacked human-associated markers such as &lt;i&gt;bla&lt;/i&gt;&lt;sub&gt;OXA-1&lt;/sub&gt;,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8b1735q6</guid>
      <pubDate>Wed, 22 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Wang, Yashan</name>
      </author>
      <author>
        <name>Park, Daniel E</name>
      </author>
      <author>
        <name>Aziz, Maliha</name>
      </author>
      <author>
        <name>Salinas, Liseth</name>
      </author>
      <author>
        <name>Sung, Edward</name>
      </author>
      <author>
        <name>Hallstrøm, Søren</name>
      </author>
      <author>
        <name>Liu, Cindy M</name>
      </author>
      <author>
        <name>Stegger, Marc</name>
      </author>
      <author>
        <name>Wu, Zhenke</name>
      </author>
      <author>
        <name>Trueba, Gabriel</name>
      </author>
      <author>
        <name>Eisenberg, Joseph NS</name>
      </author>
      <author>
        <name>Graham, Jay P</name>
      </author>
      <author>
        <name>Price, Lance B</name>
      </author>
    </item>
    <item>
      <title>Hi-C untangles the temporal dynamics of the children’s gut resistome and mobilome, highlighting the role of transposable elements</title>
      <link>https://escholarship.org/uc/item/56p010c2</link>
      <description>Many metagenomic studies lack the ability to measure the temporal dynamics of the intestinal resistome (the collection of antibiotic resistance genes [ARGs]) and mobilome (the collection of all mobile genetic elements that enable their transfer) and link the genetic features to specific species in the gut. We applied Hi-C sequencing and shotgun metagenomics to study fecal matter from children (&lt;i&gt;n &lt;/i&gt;= 15) living in semi-rural communities of Quito, Ecuador. We sampled at three different periods, with a 4- to 6-month interval between each sample collection. To understand the dynamics of ARGs from different genetic perspectives, we focused on identifying classes of mobile ARGs that are classified as high risk to human health. We selected those ARGs that appeared at least twice across sampling periods in the same child and focused the longitudinal analysis on the subset of children (&lt;i&gt;n &lt;/i&gt;= 6) where these high-risk ARGs were consistently detected. The study demonstrated the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/56p010c2</guid>
      <pubDate>Wed, 22 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Cifuentes, Sara G</name>
      </author>
      <author>
        <name>Graham, Jay</name>
        <uri>https://orcid.org/0000-0001-7062-6293</uri>
      </author>
      <author>
        <name>Trueba, Gabriel</name>
      </author>
      <author>
        <name>Cárdenas, Paúl A</name>
      </author>
    </item>
    <item>
      <title>Correction: Evaluating advance peace in Fresno, California: An interrupted times series analysis of a community-based gun violence intervention</title>
      <link>https://escholarship.org/uc/item/2375h1g3</link>
      <description>[This corrects the article DOI: 10.1371/journal.pone.0328780.].</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2375h1g3</guid>
      <pubDate>Wed, 22 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Gao, Xing</name>
      </author>
      <author>
        <name>Cabrera, Juan R</name>
      </author>
      <author>
        <name>Padilla, David</name>
      </author>
      <author>
        <name>Mujahid, Mahasin S</name>
        <uri>https://orcid.org/0000-0001-9795-9338</uri>
      </author>
      <author>
        <name>Corburn, Jason</name>
      </author>
    </item>
    <item>
      <title>The Impact of Restaurant Menu Eco Labels on Consumer Meal Selections: An RCT.</title>
      <link>https://escholarship.org/uc/item/3j99r5jz</link>
      <description>&lt;h4&gt;Introduction&lt;/h4&gt;Food systems account for ∼30% of the greenhouse gas emissions that contribute to climate change. Climate labels on restaurant menus may help consumers decrease their food-related climate impact and improve meal nutrition given that environmentally sustainable diets are also healthier. This study evaluated the degree to which different climate labels promoted healthier and lower climate impact food choices.&lt;h4&gt;Study design&lt;/h4&gt;This was an online RCT conducted in 2024, analyzed in 2025.&lt;h4&gt;Setting/participants&lt;/h4&gt;A national sample of 6,221 adults benchmarked to the U.S. Census on sex, race, ethnicity, and age was analyzed.&lt;h4&gt;Intervention&lt;/h4&gt;Participants were randomized to view a fast-food menu with either a control label or 1 of 4 climate label designs: (1) numeric, (2) climate grade, (3) traffic light, or (4) warning. Labels appeared alongside main menu items and were based on total supply chain greenhouse gas emission associated with each item. Participants...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3j99r5jz</guid>
      <pubDate>Fri, 17 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Reimold, Alexandria</name>
      </author>
      <author>
        <name>Falbe, Jennifer</name>
      </author>
      <author>
        <name>Kim, Brent</name>
      </author>
      <author>
        <name>Musicus, Aviva</name>
      </author>
      <author>
        <name>Carr, Nina</name>
      </author>
      <author>
        <name>Santo, Raychel</name>
      </author>
      <author>
        <name>Cho, Clara</name>
      </author>
      <author>
        <name>Leung, Cindy</name>
      </author>
      <author>
        <name>Roberto, Christina</name>
      </author>
      <author>
        <name>Wolfson, Julia</name>
      </author>
    </item>
    <item>
      <title>More US Pharmacies Closed Than Opened In 2018–21; Independent Pharmacies, Those In Black, Latinx Communities Most At Risk</title>
      <link>https://escholarship.org/uc/item/9hz112jd</link>
      <description>In recent years, federal and state policy makers have expressed concern about retail pharmacy closures throughout the US. However, there is a dearth of timely information on the extent of such closures. We linked data from the National Council for Prescription Drug Programs on all US retail pharmacies to county-level data from the National Center for Health Statistics and ZIP Code Tabulation Area data from the American Community Survey to determine the number and percentage of pharmacy closures during the period 2010-21; identify pharmacy, neighborhood, and market characteristics associated with pharmacy closure; and estimate the risk for closure for independent pharmacies relative to chain pharmacies. We found that of the 88,930 retail pharmacies operating during 2010-20, 29.4&amp;nbsp;percent had closed by 2021. The risk for closure for pharmacies in predominantly Black and Latinx neighborhoods was higher than in White neighborhoods. Independent pharmacies were at greater risk for...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9hz112jd</guid>
      <pubDate>Sun, 12 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
      <author>
        <name>Alexander, G Caleb</name>
      </author>
      <author>
        <name>Kanter, Genevieve P</name>
      </author>
      <author>
        <name>Qato, Dima Mazen</name>
      </author>
    </item>
    <item>
      <title>Medicare Part D Preferred Pharmacy Networks And The Risk For Pharmacy Closure, 2014–23</title>
      <link>https://escholarship.org/uc/item/9cj7n8kh</link>
      <description>Medicare Part D plans incentivize the use of specific pharmacies through preferred networks. We found that independent pharmacies and pharmacies in low-income, Black, and Latinx neighborhoods were less likely to be preferred by most Part D plans than chains and pharmacies in other neighborhoods. Pharmacies that were not preferred by most plans were 70-350&amp;nbsp;percent more likely to close than other pharmacies.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9cj7n8kh</guid>
      <pubDate>Sun, 12 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
      <author>
        <name>Alexander, G Caleb</name>
      </author>
      <author>
        <name>Kanter, Genevieve P</name>
      </author>
      <author>
        <name>Qato, Dima Mazen</name>
      </author>
    </item>
    <item>
      <title>Reassessing the Heuristic of the "Healthy Immigrant" in an Era of Turmoil.</title>
      <link>https://escholarship.org/uc/item/1kj0h9zf</link>
      <description>Reassessing the Heuristic of the "Healthy Immigrant" in an Era of Turmoil.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1kj0h9zf</guid>
      <pubDate>Sun, 12 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
    </item>
    <item>
      <title>Sociodemographic inequities in COVID-19 vaccination among adults in the United States, 2022</title>
      <link>https://escholarship.org/uc/item/0ff3r6w3</link>
      <description>BACKGROUND: Despite the availability of COVID-19 vaccines since December 2020, sociodemographic inequities in vaccination and preventable COVID-related deaths persist. To inform efforts for equitable COVID-19 vaccination campaigns, a comprehensive national evaluation of existing inequities is necessary.
OBJECTIVE: To examine sociodemographic inequities in COVID-19 vaccination receipt using data from the 2022 National Health Interview Survey (NHIS).
METHODS: This secondary data analysis used cross-sectional nationally-representative data from the 2022 NHIS to assess vaccination inequities among 27,126 adults. Separate Poisson regressions adjusted for clinical factors (e.g., age, sex, high-risk health conditions) were used to evaluate vaccination inequities across sociographic factors (e.g., race/ethnicity, poverty, health insurance).
RESULTS: In 2022, 79.6% of adults received at ≥ 1 vaccine dose, 75.0% received ≥ 2 doses ("fully vaccinated"), 45.7% received ≥ 3 doses (≥ 1 booster),...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0ff3r6w3</guid>
      <pubDate>Sun, 12 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
    </item>
    <item>
      <title>Citizenship Status and Mortality Among Young Latino Adults in the U.S., 1998‒2015</title>
      <link>https://escholarship.org/uc/item/6dm4q7cn</link>
      <description>INTRODUCTION: Although Latino immigrants, especially noncitizens, endure structural factors that may increase their risk of death at younger ages, little is known about their risk of death in young adulthood. This study evaluates mortality differences across citizenship status among young Latino adults (aged 18-44 years) in the U.S.
METHODS: This study used the National Health Interview Survey (1998-2014) with mortality follow-up through 2015. Cox regression models adjusted for age and sex were used to determine baseline differences in mortality. Models adjusted for socioeconomic factors (i.e., English proficiency, education, poverty, and health insurance) were used to determine whether socioeconomic conditions attenuate mortality differences.
RESULTS: Participants included noncitizens (n=48,388), naturalized citizens (n=16,241), and U.S.-born citizens (n=63,388). Noncitizens (hazard ratio [HR]=1.40, 95% CI=1.31, 1.51), but not naturalized citizens (HR=1.04, 95% CI=0.94, 1.16),...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6dm4q7cn</guid>
      <pubDate>Sat, 11 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
      <author>
        <name>Durazo-Arvizu, Ramon A</name>
      </author>
      <author>
        <name>Morales, Josefina Flores</name>
      </author>
      <author>
        <name>Qato, Dima M</name>
      </author>
    </item>
    <item>
      <title>Immigration Status and Disparities in the Treatment of Cardiovascular Disease Risk Factors in the Hispanic Community Health Study/Study of Latinos (Visit 2, 2014–2017)</title>
      <link>https://escholarship.org/uc/item/4xr8w700</link>
      <description>&lt;i&gt;Objectives.&lt;/i&gt; To estimate treatment rates of high cholesterol, hypertension, and diabetes among Hispanic/Latino immigrants by immigration status (i.e., naturalized citizens, documented immigrants, or undocumented immigrants).&lt;i&gt;Methods.&lt;/i&gt; We performed a cross-sectional analyses of the Hispanic Community Health Study/Study of Latinos (visit 2, 2014-2017). We restricted our analysis to Hispanic/Latino immigrants with high cholesterol (n = 3974), hypertension (n = 3353), or diabetes (n = 2406); treatment was defined as use of statins, antihypertensives, and antidiabetics, respectively.&lt;i&gt;Results.&lt;/i&gt; When compared with naturalized citizens, undocumented and documented immigrants were less likely to receive treatment for high cholesterol (38.4% vs 14.1%; prevalence ratio [PR] = 0.37 [95% confidence interval [CI] = 0.27, 0.51] and 25.7%; PR = 0.67 [95% CI = 0.58, 0.76]), hypertension (77.7% vs 57.7%; PR = 0.74 [95% CI = 0.62, 0.89] and 68.1%; PR = 0.88 [95% CI = 0.82, 0.94]),...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4xr8w700</guid>
      <pubDate>Sat, 11 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
      <author>
        <name>Durazo-Arvizu, Ramon A</name>
      </author>
      <author>
        <name>Daviglus, Martha L</name>
      </author>
      <author>
        <name>Perreira, Krista M</name>
      </author>
      <author>
        <name>Calip, Gregory S</name>
      </author>
      <author>
        <name>Nutescu, Edith A</name>
      </author>
      <author>
        <name>Gallo, Linda C</name>
      </author>
      <author>
        <name>Castaneda, Sheila F</name>
      </author>
      <author>
        <name>Gonzalez, Franklyn</name>
      </author>
      <author>
        <name>Qato, Dima M</name>
      </author>
    </item>
    <item>
      <title>Citizenship Status and the Prevalence, Treatment, and Control of Cardiovascular Disease Risk Factors Among Adults in the United States, 2011–2016</title>
      <link>https://escholarship.org/uc/item/3mm6r00b</link>
      <description>Citizenship Status and the Prevalence, Treatment, and Control of Cardiovascular Disease Risk Factors Among Adults in the United States, 2011–2016</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3mm6r00b</guid>
      <pubDate>Sat, 11 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
      <author>
        <name>Durazo-Arvizu, Ramon A</name>
      </author>
      <author>
        <name>Daviglus, Martha L</name>
      </author>
      <author>
        <name>Calip, Gregory S</name>
      </author>
      <author>
        <name>Nutescu, Edith A</name>
      </author>
      <author>
        <name>Qato, Dima M</name>
      </author>
    </item>
    <item>
      <title>The Relationship between Health Literacy and COVID-19 Vaccination Prevalence during a Rapidly Evolving Pandemic and Infodemic.</title>
      <link>https://escholarship.org/uc/item/98c282zr</link>
      <description>The gap between how health information is communicated and what people understand and can use to make informed health decisions is called health literacy. This gap was exacerbated by the rapidly changing and excessive volume of information, misinformation, and disinformation during the COVID-19 pandemic. People with lower health literacy may not have understood the importance of COVID-19 vaccination for themselves or for their communities. Our aim was to understand health literacy levels within Fulton County, Georgia, and their relationship to vaccine prevalence. Fulton county residents ages 18 and over (n = 425) completed an on-line Health Literacy Questionnaire. Individual, organizational, functional, interactive, and critical health literacy scales were created. Vaccination prevalence data were collected from the Georgia Vaccine Distribution Dashboard. All data were divided into one of three county areas. There were statistically significant variations in vaccine prevalence...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/98c282zr</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Feinberg, Iris</name>
      </author>
      <author>
        <name>Scott, Jane</name>
      </author>
      <author>
        <name>Holland, David</name>
      </author>
      <author>
        <name>Lyn, Rodney</name>
      </author>
      <author>
        <name>Scott, Lia</name>
      </author>
      <author>
        <name>Maloney, Kevin</name>
      </author>
      <author>
        <name>Rothenberg, Richard</name>
      </author>
    </item>
    <item>
      <title>Geospatial Analysis of Inflammatory Breast Cancer and Associated Community Characteristics in the United States.</title>
      <link>https://escholarship.org/uc/item/8wf9d2qn</link>
      <description>Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer, almost always diagnosed at late stage where mortality outcomes and morbidity burdens are known to be worse. Missed by mammography screening, IBC progresses rapidly and reaches late stage by the time of diagnosis. With an unknown etiology and poor prognosis, it is crucial to evaluate the distribution of the disease in the population as well as identify area social and economic contextual risk factors that may be contributing to the observed patterns of IBC incidence. In this study, we identified spatial clustering of county-based IBC rates among US females and examined the underlying community characteristics associated with the clusters. IBC accounted for ~1.25% of all primary breast cancers diagnoses in 2004-2012 and was defined by the Collaborative Stage (CS) Extension code 710 and 730. Global and local spatial clusters of IBC rates were identified and mapped. The Mann-Whitney U test was used to...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8wf9d2qn</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Scott, Lia</name>
      </author>
      <author>
        <name>Mobley, Lee</name>
      </author>
      <author>
        <name>Ilyasova, Dora</name>
      </author>
    </item>
    <item>
      <title>Are National Breast and Cervical Cancer Early Detection Program Recipients Providing Services in Counties Heavily Burdened by Breast and Cervical Cancer?</title>
      <link>https://escholarship.org/uc/item/8cj4z6rq</link>
      <description>&lt;h4&gt;Introduction&lt;/h4&gt;Alignment of National Breast and Cervical Cancer Early Detection Program (NBCCEDP) clinical services with the spatial distribution of breast and cervical cancer burden is essential to maximizing programmatic impact and addressing cancer disparities. This study identified spatial clustering of breast and cervical cancer burden scores and assessed whether and to what extent NBCCEDP clinical services were associated with clusters for the 5-year period, 2015-2019.&lt;h4&gt;Methods&lt;/h4&gt;We examined burden scores for spatial clustering using Local Indicators of Spatial Association (LISA) tests in GeoDA. We then used &lt;i&gt;t&lt;/i&gt;-tests to compare the NBCCEDP 5-year average percentage of eligible women served clinical breast and cervical cancer services between hotspot (high burden) and coolspot clusters.&lt;h4&gt;Results&lt;/h4&gt;There was statistically significant spatial clustering in the pattern of breast and cervical cancer burden scores across counties, with hotspot clusters mostly...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8cj4z6rq</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Bermudez, Yamisha</name>
      </author>
      <author>
        <name>Scott, Lia</name>
      </author>
      <author>
        <name>Miller, Jacqueline</name>
      </author>
      <author>
        <name>DeGroff, Amy</name>
      </author>
      <author>
        <name>Beckman, Michele</name>
      </author>
    </item>
    <item>
      <title>Geospatial analysis of multiple cancers in individuals in the US, 2004-2014.</title>
      <link>https://escholarship.org/uc/item/81v2d43c</link>
      <description>&lt;h4&gt;Background&lt;/h4&gt;There is a projected rapid increase in cancer survivors in the US population, from 15.5 million in 2016 to 26.1 million by 2040. Improvements in treatment and detection have led to increased survival, however, there is now a risk of developing new cancers as a result of environment toxins, behavioral risk factors, genetic predisposition, and late-term effects of radiation and chemotherapeutic treatments. This study takes a geospatial approach to examining the place of occurrence of multiple cancers originating in the population of four screenable cancers-female breast, colorectal, prostate, and cervical cancers-among the US population.&lt;h4&gt;Methods&lt;/h4&gt;During 2004-2014, 6,523,532 primary cancer patients with one of these four screenable cancers were examined, and subsequent primary cancers (multiple cancers of any type) were noted. Individual level analyses estimated the odds of diagnosis with multiple cancers controlling for age, sex, and race-ethnicity. Change...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/81v2d43c</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Scott, Lia</name>
      </author>
      <author>
        <name>Kuo, Tzy-Mey</name>
      </author>
      <author>
        <name>Ilyasova, Dora</name>
      </author>
      <author>
        <name>Mobley, Lee</name>
      </author>
    </item>
    <item>
      <title>Using Population Health Measures to Evaluate the Environmental Burden of Cancer at the County Level.</title>
      <link>https://escholarship.org/uc/item/4746t9p3</link>
      <description>&lt;h4&gt;Introduction&lt;/h4&gt;Burden of disease is often defined by using epidemiologic measures. However, there may be latent aspects of disease burden that are not factored into these types of estimates. This study quantified environmental burden of disease by using population health indicators and exploratory factor analysis at the county level across the United States.&lt;h4&gt;Methods&lt;/h4&gt;Ninety-nine variables drawn from public use data sets from 2010 to 2016 were used to create a multifactor index - the burden index. We applied principal components analysis with promax rotation to allow the factors to correlate. Correlation coefficients for each factor and the outcome of interest, age-adjusted cancer death rate, were calculated. We used both unadjusted and adjusted linear regression techniques.&lt;h4&gt;Results&lt;/h4&gt;The final additive county-level index included 9 factors that explained 68.3% of the variance in the counties and county equivalents. The burden index had a moderate association with...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4746t9p3</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Scott, Lia</name>
      </author>
      <author>
        <name>Barker, Lawrence</name>
      </author>
      <author>
        <name>Richardson, Lisa</name>
      </author>
    </item>
    <item>
      <title>Comparing direct oral anticoagulants and vitamin K antagonist use in morbidly obese patients with venous thromboembolism: A single center retrospective cohort study.</title>
      <link>https://escholarship.org/uc/item/2571g06d</link>
      <description>&lt;b&gt;Introduction&lt;/b&gt;: Limited data exists on the safety and efficacy of direct-acting oral anticoagulants (DOAC) use in morbidly obese patients with venous thromboembolism (VTE). Given the benefits of DOAC use over vitamin K antagonists (VKAs), in terms of monitoring requirements, and dietary and drug interactions, it is important to evaluate whether this is consistent in the higher risk for VTE recurrence morbidly obese group body mass index (BMI ≥ 40&amp;nbsp;kg/m&lt;sup&gt;2&lt;/sup&gt;). &lt;b&gt;Materials and methods&lt;/b&gt;: This retrospective, single-center cohort study included patients with a BMI of at least 40&amp;nbsp;kg/m&lt;sup&gt;2&lt;/sup&gt; who were admitted to Emory University Hospital from 1&lt;sup&gt;st&lt;/sup&gt; January 2012 to 31&lt;sup&gt;st&lt;/sup&gt; May 2020 with acute VTE, and subsequently initiated on anticoagulation treatment with either DOAC or VKA (warfarin). Univariate and bivariate analyses were used to evaluate differences in demographics by treatment type and BMI. Multivariate Cox proportional hazard regression...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2571g06d</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Scott, Lia</name>
      </author>
      <author>
        <name>Li, Juan</name>
      </author>
      <author>
        <name>Cafuir, Lorraine</name>
      </author>
      <author>
        <name>Gaddh, Manila</name>
      </author>
      <author>
        <name>Kempton, Christine</name>
      </author>
    </item>
    <item>
      <title>Modeling Geospatial Patterns of Late-Stage Diagnosis of Breast Cancer in the US.</title>
      <link>https://escholarship.org/uc/item/1fn168q4</link>
      <description>In the US, about one-third of new breast cancers (BCs) are diagnosed at a late stage, where morbidity and mortality burdens are higher. Health outcomes research has focused on the contribution of measures of social support, particularly the residential isolation or segregation index, on propensity to utilize mammography and rates of late-stage diagnoses. Although inconsistent, studies have used various approaches and shown that residential segregation may play an important role in cancer morbidities and mortality. Some have focused on any individuals living in residentially segregated places (place-centered), while others have focused on persons of specific races or ethnicities living in places with high segregation of their own race or ethnicity (person-centered). This paper compares and contrasts these two approaches in the study of predictors of late-stage BC diagnoses in a cross-national study. We use 100% of U.S. Cancer Statistics (USCS) Registry data pooled together from...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1fn168q4</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Mobley, Lee</name>
      </author>
      <author>
        <name>Kuo, Tzy-Mey</name>
      </author>
      <author>
        <name>Scott, Lia</name>
      </author>
      <author>
        <name>Rutherford, Yamisha</name>
      </author>
      <author>
        <name>Bose, Srimoyee</name>
      </author>
    </item>
    <item>
      <title>Predicted Heart Age Among Cancer Survivors - United States, 2013-2017.</title>
      <link>https://escholarship.org/uc/item/19s233s8</link>
      <description>Approximately 15.5 million cancer survivors were alive in the United States in 2016 with expected growth to 26.1 million by 2040 (1). Cancer survivors are living longer because of advances in early detection and treatment, but face psychosocial, cognitive, financial, and physical challenges (1,2). Physical challenges include cardiovascular complications, partly because cancer and cardiovascular disease (CVD) share some cumulative risk factors including tobacco use, physical inactivity, obesity, poor diet, hypertension, diabetes, and dyslipidemia (3). In addition, many cancer treatments damage the heart, and some cancer types increase risk for developing CVD (4). The recognition and management of heart disease in cancer survivors has given rise to the discipline of cardio-oncology, which focuses on the cardiovascular health of this population (5). CVD risk has been previously estimated using prediction models, and studies suggest that physician-patient communication using predicted...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/19s233s8</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Scott, Lia</name>
      </author>
      <author>
        <name>Yang, Quanhe</name>
      </author>
      <author>
        <name>Dowling, Nicole</name>
      </author>
      <author>
        <name>Richardson, Lisa</name>
      </author>
    </item>
    <item>
      <title>Acceptability of Primary Care Counseling and Brief Educational Messages to Increase Awareness about Alcohol and Breast Cancer Risks among Bisexual and Lesbian Women.</title>
      <link>https://escholarship.org/uc/item/0zx1q2x2</link>
      <description>This research had two aims: (1) to assess how often bisexual and lesbian women self-report screening and counseling for alcohol use in primary care settings; and (2) understand how bisexual and lesbian women respond to brief messages that alcohol increases breast cancer risk. The study sample consisted of 4891 adult U.S. women who responded to an online, cross-sectional Qualtrics survey in September-October 2021. The survey included the Alcohol Use Disorders Identification Test (AUDIT), questions about alcohol screening and brief counseling in primary care, and questions assessing awareness of the link between alcohol use and breast cancer. Bivariate analyses and logistic regression were conducted. Bisexual and lesbian women had higher odds of harmful drinking (AUDIT score ≥ 8) than heterosexual women (adjusted odds ratio [AOR] = 1.26, 95% confidence interval [CI] = 1.01-1.57 for bisexual women; AOR =1.78, 95% CI = 1.24-2.57 for lesbian women). However, bisexual and lesbian women...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0zx1q2x2</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Balenger, Adelaide</name>
      </author>
      <author>
        <name>Scott, Lia</name>
      </author>
      <author>
        <name>Swahn, Monica</name>
      </author>
      <author>
        <name>Aneja, Ritu</name>
      </author>
    </item>
    <item>
      <title>Using residential segregation to predict colorectal cancer stage at diagnosis: two different approaches.</title>
      <link>https://escholarship.org/uc/item/0wp0k2jc</link>
      <description>&lt;h4&gt;Purpose&lt;/h4&gt;Studies have found a variety of evidence regarding the association between residential segregation measures and health outcomes in the United States. Some have focused on any individuals living in residentially segregated places, whereas others have examined whether persons of specific races or ethnicities living in places with high segregation of their own race or ethnicity have differential outcomes. This article compares and contrasts these two approaches in the study of predictors of late-stage colorectal cancer (CRC) diagnoses in a cross-national study. We argue that it is very important when interpreting results from studies like this to carefully consider the geographic scope of the analysis, which can significantly change the context and meaning of the results.&lt;h4&gt;Methods&lt;/h4&gt;We use US Cancer Statistics Registry data from 40 states to identify late-stage diagnoses among over 500,000 CRC cases diagnosed during 2004-2009. We pool data over the states and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0wp0k2jc</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Mobley, Lee</name>
      </author>
      <author>
        <name>Scott, Lia</name>
      </author>
      <author>
        <name>Rutherford, Yamisha</name>
      </author>
      <author>
        <name>Kuo, Tzy-Mey</name>
      </author>
    </item>
    <item>
      <title>A livelihood intervention improved nutritional, mental health and sexual health outcomes among HIV-affected adolescents in western Kenya: results from the Shamba Maisha randomised controlled trial</title>
      <link>https://escholarship.org/uc/item/9qr213k1</link>
      <description>INTRODUCTION: Interventions that address household-level factors, including food insecurity (FI) and poverty, may reduce HIV risk and improve sexual and reproductive health (SRH) among adolescent girls and young women (AGYW).
METHODS: This cluster randomised controlled trial in Kenya assessed AGYW living in households of adults enrolled in &lt;i&gt;Shamba Maisha&lt;/i&gt; (SM). SM was a multisectoral agricultural livelihood intervention designed to improve HIV health. At the trial end, we used linear and logistic regressions to compare differences between the intervention and control arms in FI, and mental health among AGYW-caregiver pairs and SRH outcomes among the AGYW, accounting for clusters with robust standard errors. We also conducted a secondary analysis among 15-19 years whose caregivers were SM participants.
RESULTS: The study enrolled 241 AGYW-caregiver pairs (n=131 intervention). The median age of AGYW was 15 years old (IQR: 14-17 years old). At endline, AGYW in intervention households...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9qr213k1</guid>
      <pubDate>Wed, 8 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Weiser, Sheri D</name>
      </author>
      <author>
        <name>Sheira, Lila Aziz</name>
        <uri>https://orcid.org/0000-0002-1831-8506</uri>
      </author>
      <author>
        <name>Wekesa, Pauline</name>
      </author>
      <author>
        <name>Zakaras, Jennifer Monroe</name>
      </author>
      <author>
        <name>Frongillo, Edward A</name>
      </author>
      <author>
        <name>Weke, Elly</name>
      </author>
      <author>
        <name>Nagata, Jason M</name>
      </author>
      <author>
        <name>Conroy, Amy A</name>
      </author>
      <author>
        <name>Lightfoot, Marguerita</name>
      </author>
      <author>
        <name>Neilands, Torsten B</name>
      </author>
      <author>
        <name>Butler, Lisa M</name>
      </author>
      <author>
        <name>Bukusi, Elizabeth A</name>
      </author>
      <author>
        <name>Cohen, Craig R</name>
        <uri>https://orcid.org/0000-0001-8654-6634</uri>
      </author>
      <author>
        <name>Onono, Maricianah Atieno</name>
      </author>
    </item>
    <item>
      <title>Regional Increases in Incidence of Coccidioidomycosis (Valley Fever) - Arizona, 2005-2022.</title>
      <link>https://escholarship.org/uc/item/8pj6d80m</link>
      <description>Incidence of coccidioidomycosis (Valley fever), a fungal infection caused by inhalation of Coccidioides species spores, has increased substantially across the southwestern United States in association with increasing aridity, warming temperatures, and precipitation volatility. Arizona and California report &amp;gt;95% of U.S. coccidioidomycosis cases, and incidence in Arizona has increased statewide. Patterns within Arizona's distinct climatological regions have not been characterized, especially in regions outside the known zone of persistently high levels of disease occurrence (hyperendemicity) in the southwest Sonoran Desert region. In this study, surveillance data reported to the Arizona Department of Health Services since 2005 were used to calculate coccidioidomycosis incidence within six ecological regions. During 2005-2022, annual incidence approximately doubled in Arizona, with &amp;gt;95% of cases reported from the Sonoran Desert region. Although the Plateaus and Mojave Desert...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8pj6d80m</guid>
      <pubDate>Thu, 26 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Kruger, Sophia E</name>
      </author>
      <author>
        <name>Ruberto, Irene</name>
      </author>
      <author>
        <name>Williamson, Thomas</name>
      </author>
      <author>
        <name>Remais, Justin V</name>
        <uri>https://orcid.org/0000-0002-0223-4615</uri>
      </author>
      <author>
        <name>Heaney, Alexandra K</name>
      </author>
      <author>
        <name>Head, Jennifer R</name>
      </author>
    </item>
    <item>
      <title>Epidemiology of Aspergillosis Diagnoses in US Adults Using a National EHR Database, 2013–2023</title>
      <link>https://escholarship.org/uc/item/1bt6p903</link>
      <description>Background: Aspergillosis is a fungal infection associated with rising hospitalizations and substantial morbidity and mortality. In the United States, data remain fragmented due to the absence of centralized surveillance. This study aimed to evaluate demographic, geographic, and temporal trends in aspergillosis diagnoses across the United States and evaluate changes in those patterns following the emergence of COVID-19.
Methods: We conducted a retrospective cohort study using electronic health record data from 142 US healthcare systems (Oracle Health), including adults aged ≥18 years who received care between 2013 and 2023. The cohort included over 76 million patients and 127 million person-years. Aspergillosis prevalence was calculated using post-stratification weights. Adjusted prevalence ratios (aPRs) were estimated via quasi-Poisson and Bayesian spatiotemporal regression. COVID-19-related shifts were evaluated using estimated marginal means.
Results: From 2013 to 2023, aspergillosis...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1bt6p903</guid>
      <pubDate>Thu, 26 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Bustamante, Brittany L Morgan</name>
        <uri>https://orcid.org/0000-0002-0280-0904</uri>
      </author>
      <author>
        <name>Martinez, Elijah G</name>
      </author>
      <author>
        <name>Lee, Aidan</name>
      </author>
      <author>
        <name>Kane, Natalie J</name>
      </author>
      <author>
        <name>Camponuri, Simon K</name>
      </author>
      <author>
        <name>Reynolds, Rose M</name>
      </author>
      <author>
        <name>Snow, Theo T</name>
      </author>
      <author>
        <name>Bartels, Juliana GE</name>
      </author>
      <author>
        <name>Hoffman, Mark</name>
      </author>
      <author>
        <name>White, Theodore C</name>
      </author>
      <author>
        <name>Remais, Justin V</name>
        <uri>https://orcid.org/0000-0002-0223-4615</uri>
      </author>
    </item>
    <item>
      <title>Citizenship status and cost‐related nonadherence in the United States, 2017–2021</title>
      <link>https://escholarship.org/uc/item/6s9031dg</link>
      <description>OBJECTIVE: To assess inequities in prescription medication use and subsequent cost-related nonadherence (CRN) and cost-saving strategies by citizenship status in the United States.
DATA SOURCES/STUDY SETTING: National Health Interview Survey (2017-2021).
STUDY DESIGN: This cross-sectional study examined noncitizen (n = 8596), naturalized citizen (n = 12,800), and US-born citizen (n = 120,195) adults. We also examined older adults (≥65 years) separately, including noncitizens without Medicare (a group of importance given their immigration-related barriers to health care access). Multiple mediation analysis was used to examine differences in CRN and determine whether economic, health care, and immigration factors explain observed inequities.
PRINCIPAL FINDINGS: Noncitizens (41.9%) were less likely to use prescription medications than naturalized (60.5%) and US-born citizens (68.2%). Among prescription medication users, noncitizens (13.8%) were more likely to report CRN than naturalized...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6s9031dg</guid>
      <pubDate>Tue, 17 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
      <author>
        <name>Qato, Dima M</name>
      </author>
    </item>
    <item>
      <title>Evaluating External Validity of Oncology Biosimilar Safety Studies</title>
      <link>https://escholarship.org/uc/item/6s15x8qd</link>
      <description>Evaluating External Validity of Oncology Biosimilar Safety Studies</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6s15x8qd</guid>
      <pubDate>Mon, 16 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Calip, Gregory S</name>
      </author>
      <author>
        <name>Altomare, Ivy P</name>
      </author>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
    </item>
    <item>
      <title>Examining the Associations Among Treatment Declination, Racial and Ethnic Inequities, and Breast Cancer Survival</title>
      <link>https://escholarship.org/uc/item/6q41b2rr</link>
      <description>Examining the Associations Among Treatment Declination, Racial and Ethnic Inequities, and Breast Cancer Survival</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6q41b2rr</guid>
      <pubDate>Mon, 16 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Calip, Gregory S</name>
      </author>
      <author>
        <name>Hoskins, Kent F</name>
      </author>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
    </item>
    <item>
      <title>Global, regional and national trends in statin utilisation in high-income and low/middle-income countries, 2015–2020</title>
      <link>https://escholarship.org/uc/item/3wn1x9rw</link>
      <description>OBJECTIVE: Prior studies have reported inequitable global access to essential medicines for cardiovascular disease (CVD) prevention, especially statins. Here we examine recent trends and disparities in statin utilisation at the income group, regional and country levels.
DESIGN: Ecological study. Pharmaceutical sales data were used to examine statin utilisation in high-income counties (HICs) and low/middle-income countries (LMICs) from 2015 to 2020. Population estimates were obtained from the Global Burden of Disease. Fixed-effects panel regression analysis was used to examine associations between statin utilisation and country-level factors.
SETTING: Global, including 41 HICs and 50 LMICs.
PARTICIPANTS: Population older than 40 years of age.
PRIMARY AND SECONDARY OUTCOME MEASURES: Statin utilisation was measured using defined daily doses (DDDs) per 1000 population ≥40 years per day (TPD).
RESULTS: Globally, statin utilisation increased 24.7% from 54.7 DDDs/TPD in 2015 to 68.3...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3wn1x9rw</guid>
      <pubDate>Mon, 16 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
      <author>
        <name>Shooshtari, Andrew</name>
      </author>
      <author>
        <name>Qato, Dima M</name>
      </author>
    </item>
    <item>
      <title>Racialized economic segregation and inequities in treatment initiation and survival among patients with metastatic breast cancer</title>
      <link>https://escholarship.org/uc/item/2zn0764g</link>
      <description>PurposeRacialized economic segregation, a form of structural racism, may drive persistent inequities among patients with breast cancer. We examined whether a composite area-level index of racialized economic segregation was associated with real-world treatment and survival in metastatic breast cancer (mBC).MethodsWe conducted a retrospective cohort study among adult women with mBC using a US nationwide electronic health record-derived de-identified database (2011–2022). Population-weighted quintiles of the index of concentration at the extremes were estimated using census tract data. To identify inequities in time to treatment initiation (TTI) and overall survival (OS), we employed Kaplan–Meier methods and estimated hazard ratios (HR) adjusted for clinical factors.ResultsThe cohort included 27,459 patients. Compared with patients from the most privileged areas, those from the least privileged areas were disproportionately Black (36.9% vs. 2.6%) or Latinx (13.2% vs. 2.6%) and increasingly...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2zn0764g</guid>
      <pubDate>Mon, 16 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Pittell, Harlan</name>
      </author>
      <author>
        <name>Calip, Gregory S</name>
      </author>
      <author>
        <name>Pierre, Amy</name>
      </author>
      <author>
        <name>Ryals, Cleo A</name>
      </author>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
    </item>
    <item>
      <title>Racial and Ethnic Inequities in US Oncology Clinical Trial Participation From 2017 to 2022</title>
      <link>https://escholarship.org/uc/item/1x71w5z4</link>
      <description>Importance: There is increasing recognition from regulatory agencies that racial and ethnic representation in clinical trials is inadequate and linked to health inequities. The extent of racial inequities in clinical trial participation is unclear because prior studies have synthesized enrollment data from published trials, which often do not report participant race and ethnicity.
Objective: To evaluate racial and ethnic inequities in oncology clinical trial participation in a contemporary cohort of patients with cancer before and during the COVID-19 pandemic.
Design, Setting, and Participants: This cohort study used a nationwide electronic health record-derived deidentified database, which includes data for approximately 280 US cancer clinics (approximately 800 sites of care). The study included Latinx, non-Latinx Black (hereinafter, Black), and non-Latinx White (reference; hereinafter, White) patients aged 18 years or older who had been diagnosed with advanced non-small cell...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1x71w5z4</guid>
      <pubDate>Mon, 16 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Pittell, Harlan</name>
      </author>
      <author>
        <name>Calip, Gregory S</name>
      </author>
      <author>
        <name>Pierre, Amy</name>
      </author>
      <author>
        <name>Ryals, Cleo A</name>
      </author>
      <author>
        <name>Altomare, Ivy</name>
      </author>
      <author>
        <name>Royce, Trevor J</name>
      </author>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
    </item>
    <item>
      <title>Socioeconomic status and inequities in treatment initiation and survival among patients with cancer, 2011-2022</title>
      <link>https://escholarship.org/uc/item/09851283</link>
      <description>BACKGROUND: Lower neighborhood socioeconomic status (SES) is associated with suboptimal cancer care and reduced survival. Most studies examining cancer inequities across area-level socioeconomic status tend to use less granular or unidimensional measures and pre-date the COVID-19 pandemic. Here, we examined the association of area-level socioeconomic status on real-world treatment initiation and overall survival among adults with 20 common cancers.
METHODS: This retrospective cohort study used electronic health record-derived deidentified data (Flatiron Health Research Database, 2011-2022) linked to US Census Bureau data from the American Community Survey (2015-2019). Area-level socioeconomic status quintiles (based on a measure incorporating income, home values, rental costs, poverty, blue-collar employment, unemployment, and education information) were computed from the US population and applied to patients based on their mailing address. Associations were examined using Cox...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/09851283</guid>
      <pubDate>Mon, 16 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
      <author>
        <name>Wang, Xiaoliang</name>
      </author>
      <author>
        <name>Ryals, Cleo A</name>
      </author>
      <author>
        <name>Miksad, Rebecca A</name>
      </author>
      <author>
        <name>Snider, Jeremy</name>
      </author>
      <author>
        <name>Walters, James</name>
      </author>
      <author>
        <name>Calip, Gregory S</name>
      </author>
    </item>
    <item>
      <title>Sociodemographic Inequities in Telemedicine Use Among US Patients Initiating Treatment in Community Cancer Centers During the Ongoing COVID-19 Pandemic, 2020-2022</title>
      <link>https://escholarship.org/uc/item/08v4v8fx</link>
      <description>PURPOSE: Although telemedicine was seen as a way to improve cancer care during the coronavirus disease (COVID-19) pandemic, there is limited information regarding inequities in its uptake. This study assessed sociodemographic factors associated with telemedicine use among patients initiating treatment for 20 common cancers.
METHODS: This retrospective cohort study used deidentified electronic health record-derived patient data from a nationwide network of community cancer practices, linked to area-level Census information. We included adults (age 18 years and older) who initiated first-line systemic cancer treatment between March 2020 and December 2022 (follow-up through March 2023). Exposures include race/ethnicity, insurance status, and area-level social determinants of health (eg, block group socioeconomic status [SES]). The outcome was telemedicine use within 90 days after treatment initiation. Associations were examined using logistic regression models adjusted for age, sex,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/08v4v8fx</guid>
      <pubDate>Mon, 16 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
      <author>
        <name>Wang, Xiaoliang</name>
      </author>
      <author>
        <name>Royce, Trevor J</name>
      </author>
      <author>
        <name>Calip, Gregory S</name>
      </author>
    </item>
    <item>
      <title>Mediators of racial and ethnic inequities in clinical trial participation among patients with cancer, 2011-2023</title>
      <link>https://escholarship.org/uc/item/5c83v7g9</link>
      <description>BACKGROUND: Although racially and ethnically minoritized populations are less likely to participate in cancer trials, it is unknown whether social determinants of health (SDOH) explain these inequities. Here we identify SDOH factors that contribute to racial and ethnic inequities in clinical trial participation among patients with 22 common cancers.
METHODS: This retrospective cohort study used electronic health record data (2011-2023) linked to neighborhood (US Census tract) data from multiple sources. Patients were followed from diagnosis to clinical study drug receipt (proxy for trial participation), death, or last recorded activity. Associations were assessed using Cox proportional hazards models adjusted for clinical factors (year of diagnosis, age, sex, performance status, disease stage, cancer type). To elucidate which area-level SDOH underlie racial and ethnic inequities, mediation analysis was performed using nonlinear multiple additive regression tree models.
RESULTS:...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5c83v7g9</guid>
      <pubDate>Sat, 14 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
      <author>
        <name>Wang, Xiaoliang</name>
      </author>
      <author>
        <name>Altomare, Ivy</name>
      </author>
      <author>
        <name>Castillo, Wendy Camelo</name>
      </author>
      <author>
        <name>Sarkar, Somnath</name>
      </author>
      <author>
        <name>Mamtani, Ronac</name>
      </author>
      <author>
        <name>Calip, Gregory S</name>
      </author>
    </item>
    <item>
      <title>Machine learning to optimize precision in the analysis of randomized trials: A journey in pre-specified, yet data-adaptive learning</title>
      <link>https://escholarship.org/uc/item/93b309xc</link>
      <description>Covariate adjustment is an approach to improve the precision of trial analyses by adjusting for baseline variables that are prognostic of the primary endpoint. Motivated by the SEARCH Universal HIV Test-and-Treat Trial (2013-2017), we tell our story of developing, evaluating, and implementing a machine learning-based approach for covariate adjustment. We provide the rationale for as well as the practical concerns with such an approach for estimating marginal effects. Using schematics, we illustrate our procedure: targeted machine learning estimation (TMLE) with Adaptive Pre-specification. Briefly, sample-splitting is used to data-adaptively select the combination of estimators of the outcome regression (i.e. the conditional expectation of the outcome given the trial arm and covariates) and known propensity score (i.e. the conditional probability of being randomized to the intervention given the covariates) that minimizes the cross-validated variance estimate and, thereby, maximizes...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/93b309xc</guid>
      <pubDate>Thu, 12 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Balzer, Laura B</name>
      </author>
      <author>
        <name>van der Laan, Mark J</name>
      </author>
      <author>
        <name>Petersen, Maya L</name>
        <uri>https://orcid.org/0000-0003-4941-2041</uri>
      </author>
    </item>
    <item>
      <title>Medicaid Expansion for Undocumented Adults and its Association with Health Insurance Coverage among Noncitizens in California, 2017-2023</title>
      <link>https://escholarship.org/uc/item/8zd631gz</link>
      <description>Abstract  Introduction California's 4.8 million noncitizen adults, half of whom are undocumented, endure substantial exclusions from health care. To address this gap, California policymakers expanded full-scope, state-funded Medicaid without discriminating by immigration status, first extending coverage to undocumented young adults (18-25 years) in 2020 and then to older adults (≥50 years) in 2022.   Methods Using the American Community Survey (2017-2023), we assessed whether California’s Medicaid expansion for young and older undocumented adults was associated with changes in insurance coverage by comparing pre- and post-expansion differences between citizens and noncitizens (difference-in-differences).   Results Compared to citizens, the expansion was not associated with increased health insurance or Medicaid enrollment among young noncitizens. However, among older adults, the expansion was associated with a modest 1.3% increase in overall insurance coverage for noncitizens,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8zd631gz</guid>
      <pubDate>Wed, 11 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Guadamuz, Jenny S</name>
        <uri>https://orcid.org/0000-0002-2312-4140</uri>
      </author>
      <author>
        <name>Chen, Stacy</name>
      </author>
      <author>
        <name>Bustamante, Arturo Vargas</name>
        <uri>https://orcid.org/0000-0003-0414-5015</uri>
      </author>
    </item>
    <item>
      <title>Proposed Key Characteristics of Neurotoxic Chemicals</title>
      <link>https://escholarship.org/uc/item/7wp0129j</link>
      <description>A critical component of evaluating whether a chemical can cause human neurotoxicity is hazard identification, which typically involves a comprehensive literature search to identify and synthesize epidemiological, animal, and mechanistic data for the chemical of interest. The key characteristics (KCs) concept has proven to be a useful tool for searching, organizing, and evaluating mechanistic data for hazard identification. KCs are the established chemical and biological properties of known human neurotoxic agents based on understanding of their mechanisms of neurotoxicity. KCs were originally developed for carcinogens but have now also been published for endocrine- and metabolism-disruptors and various organ-selective toxic chemicals. To identify KCs associated with neurotoxic chemicals, an expert committee was convened to consider current mechanistic understanding of chemicals known to be neurotoxic in humans with the goal of identifying established molecular and cellular actions...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7wp0129j</guid>
      <pubDate>Wed, 11 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Lein, Pamela J</name>
        <uri>https://orcid.org/0000-0001-7665-7584</uri>
      </author>
      <author>
        <name>Bowman, Aaron B</name>
      </author>
      <author>
        <name>Cao, Zhengyu</name>
      </author>
      <author>
        <name>Carson, Monica</name>
      </author>
      <author>
        <name>Eskenazi, Brenda</name>
        <uri>https://orcid.org/0000-0001-7609-6852</uri>
      </author>
      <author>
        <name>Fritsche, Ellen</name>
      </author>
      <author>
        <name>Harry, G Jean</name>
      </author>
      <author>
        <name>Hartung, Thomas</name>
      </author>
      <author>
        <name>Pessah, Isaac N</name>
      </author>
      <author>
        <name>Slikker, William</name>
      </author>
      <author>
        <name>Zeise, Lauren</name>
      </author>
      <author>
        <name>Smith, Martyn T</name>
      </author>
    </item>
    <item>
      <title>Ambient air pollutant mixture and lung function among children in Fresno, California</title>
      <link>https://escholarship.org/uc/item/1mp1z40q</link>
      <description>BACKGROUND: Ambient air pollutants such as particulate matter (PM), ozone (O3), and nitrogen dioxide (NO2) have been associated with lower lung function among children. However, the reported associations could be due to correlation with other pollutants.
OBJECTIVE: We investigate the relationships between exposures to eight ambient air pollutants and children's lung function and apply mixture analysis to identify key contributors to health effects.
METHODS: The Children's Health and Air Pollution Study (CHAPS) in Fresno, California, is a prospective cohort study that recruited 299 children and assessed their lung function at two visits, at approximately 7 and 9 years of age. The children's forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), and FEV1/FVC ratio were standardized using the Global Lung Function Initiative (GLI) race-neutral calculators. We assessed the children's average daily residential exposures to PM2.5, PM10, nitrogen oxides (NOx),...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1mp1z40q</guid>
      <pubDate>Tue, 24 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Lu, Wenxin</name>
        <uri>https://orcid.org/0000-0003-3861-9143</uri>
      </author>
      <author>
        <name>Eisen, Ellen A</name>
        <uri>https://orcid.org/0000-0002-5114-5264</uri>
      </author>
      <author>
        <name>Lutzker, Liza</name>
      </author>
      <author>
        <name>Noth, Elizabeth</name>
        <uri>https://orcid.org/0000-0002-9159-6924</uri>
      </author>
      <author>
        <name>Tyner, Tim</name>
      </author>
      <author>
        <name>Lurmann, Fred</name>
      </author>
      <author>
        <name>Hammond, S Katharine</name>
      </author>
      <author>
        <name>Holm, Stephanie</name>
        <uri>https://orcid.org/0000-0001-5200-1716</uri>
      </author>
      <author>
        <name>Balmes, John R</name>
        <uri>https://orcid.org/0000-0002-2246-7002</uri>
      </author>
    </item>
    <item>
      <title>Post-chikungunya chronic inflammatory rheumatism: results from a retrospective follow-up study of 283 adult and child cases in La Virginia, Risaralda, Colombia.</title>
      <link>https://escholarship.org/uc/item/8r20n0w6</link>
      <description>&lt;h4&gt;Objective&lt;/h4&gt;There are limited studies in Latin America regarding the chronic consequences of the Chikungunya virus (CHIK), such as post-CHIK chronic inflammatory rheumatism (pCHIK-CIR). We assessed the largest cohort so far of pCHIK-CIR in Latin America, at the municipality of La Virginia, Risaralda, a new endemic area of CHIK in Colombia.&lt;h4&gt;Methods&lt;/h4&gt;We conducted a cohort retrospective study in Colombia of 283 patients diagnosed with CHIK that persisted with pCHIK-CIR after a minimum of 6 weeks and up to a maximum of 26.1 weeks. pCHIK cases were identified according to validated criteria via telephone.&lt;h4&gt;Results&lt;/h4&gt;Of the total CHIK-infected subjects, 152 (53.7%) reported persistent rheumatological symptoms (pCHIK-CIR). All of these patients reported joint pains (chronic polyarthralgia, pCHIK-CPA), 49.5% morning stiffness, 40.6% joint edema, and 16.6% joint redness. Of all patients, 19.4% required and attended for care prior to the current study assessment (1.4% consulting...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8r20n0w6</guid>
      <pubDate>Thu, 29 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Rodriguez-Morales, Alfonso</name>
      </author>
      <author>
        <name>Gil-Restrepo, Andrés</name>
      </author>
      <author>
        <name>Ramírez-Jaramillo, Valeria</name>
      </author>
      <author>
        <name>Montoya-Arias, Cindy</name>
      </author>
      <author>
        <name>Acevedo-Mendoza, Wilmer</name>
      </author>
      <author>
        <name>Bedoya-Arias, Juan</name>
      </author>
      <author>
        <name>Chica-Quintero, Laura</name>
      </author>
      <author>
        <name>Murillo-García, David</name>
      </author>
      <author>
        <name>García-Robledo, Juan</name>
      </author>
      <author>
        <name>Castrillón-Spitia, Juan</name>
      </author>
      <author>
        <name>Londoño, Jose</name>
      </author>
      <author>
        <name>Bedoya-Rendón, Hector</name>
      </author>
      <author>
        <name>Cárdenas-Pérez, Javier</name>
      </author>
      <author>
        <name>Cardona-Ospina, Jaime</name>
      </author>
      <author>
        <name>Lagos-Grisales, Guillermo</name>
      </author>
    </item>
  </channel>
</rss>
